<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21589911</article-id><article-id pub-id-type="pmc">3093377</article-id><article-id pub-id-type="publisher-id">PONE-D-10-05991</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0018948</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Antivirals</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical Research Design</subject><subj-group><subject>Epidemiology</subject><subject>Meta-Analyses</subject><subject>Systematic Reviews</subject></subj-group></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Clinical Epidemiology</subject><subject>Epidemiological Methods</subject><subject>Infectious Disease Epidemiology</subject><subject>Social Epidemiology</subject></subj-group></subj-group><subj-group><subject>Global Health</subject></subj-group><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Sexually Transmitted Diseases</subject><subj-group><subject>AIDS</subject></subj-group></subj-group><subj-group><subject>Viral Diseases</subject><subj-group><subject>HIV</subject><subj-group><subject>HIV diagnosis and management</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Non-Clinical Medicine</subject><subj-group><subject>Health Services Research</subject><subject>Socioeconomic Aspects of Health</subject></subj-group></subj-group><subj-group><subject>Public Health</subject></subj-group></subj-group></article-categories><title-group><article-title>Livelihood Security and Adherence to Antiretroviral Therapy in Low and Middle Income Settings: A Systematic Review</article-title><alt-title alt-title-type="running-head">Livelihood and Adherence to Antiretroviral Therapy</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rachlis</surname><given-names>Beth S.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mills</surname><given-names>Edward J.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cole</surname><given-names>Donald C.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Faculty of Health Sciences, University of Ottawa, Ottawa, Canada</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Maartens</surname><given-names>Gary</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Cape Town, South Africa</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>beth.rachlis@utoronto.ca</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: BR DCC. Performed the experiments: BR DCC EM. Analyzed the data: BR EM. Wrote the paper: BR DCC EM.</p></fn></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>12</day><month>5</month><year>2011</year></pub-date><volume>6</volume><issue>5</issue><elocation-id>e18948</elocation-id><history><date date-type="received"><day>30</day><month>11</month><year>2010</year></date><date date-type="accepted"><day>18</day><month>3</month><year>2011</year></date></history><permissions><copyright-statement>Rachlis et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2011</copyright-year></permissions><abstract><sec><title>Introduction</title><p>We sought to examine the association between livelihood security and adherence to antiretroviral therapy (ARVs) in low- and middle-income countries (LIMC).</p></sec><sec><title>Methods</title><p>Performing a systematic review, we searched, independently and in duplicate, 7 electronic databases and 2 conference websites for quantitative surveys that examined the association between indicators of livelihood security and adherence to ARVs in LIMC between 2000&#x02013;2010. Criteria for relevance were applied to complete papers (quantitative study with estimates of associations) and quality assessment was conducted on those deemed relevant. We performed three regressions to measure the association between each type of livelihood and adherence.</p></sec><sec><title>Results</title><p>Twenty original studies and 6 conference abstracts were included, the majority from Africa (n&#x0200a;=&#x0200a;16). Seventeen studies and 3 conference abstracts were cross-sectional and 3 studies and 3 abstracts were prospective clinical cohort studies, with considerable variation in quality for studies of each design type. Among the diverse populations represented, we observed considerable variation in associations between measurements of livelihood indicators and increasingly accepted adherence measures, irrespective of study design or quality. A financial capital indicator, financial constraints/payment for ARV medication, was more commonly associated with non-adherence (3/5 studies). A human capital indicator, educational level, was most commonly associated with adherence (11/20 studies).</p></sec><sec><title>Discussion</title><p>Additional better quality research examining livelihood security is required to inform provision of optimal supports for adherence and mitigation of the impacts of HIV/AIDS.</p></sec></abstract><counts><page-count count="15"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The HIV/AIDS epidemic has taken a particular toll on low- and middle-income countries (LIMC), with sub-Saharan Africa heavily affected by both disease and poverty. Among the many challenges faced by clinicians and AIDS organizations are maintaining health in the face of poverty that may preclude access to food and medication adherence <xref ref-type="bibr" rid="pone.0018948-Drimie1">[1]</xref>. Although several development initiatives have been established by different AIDS organizations, such as micro-finance and support groups, little is understood about the impact of livelihood security and its eventual impact on long-term patient status, including mortality.</p><p>Livelihood is closely linked to socio-economic status (SES), a term often used to reflect an individual's access to resources such as food, potable water, health facilities, educational opportunities, and housing <xref ref-type="bibr" rid="pone.0018948-Drimie1">[1]</xref>, <xref ref-type="bibr" rid="pone.0018948-Elasha1">[2]</xref>. Assets include the types of capital that can be used directly or indirectly to generate livelihoods and reflect natural (e.g., land, water), physical (e.g., infrastructure, roads), financial (e.g., money, savings, income), human (e.g., knowledge, education, ability to work), and social (e.g., networks, kin, membership in a group) forms <xref ref-type="bibr" rid="pone.0018948-Carney1">[3]</xref>. A livelihood approach, as a framework, explores how individuals, households, or communities behave under specific conditions, analyzing their ability to cope and adapt in response to external shocks such as drought or civil strife <xref ref-type="bibr" rid="pone.0018948-DeWaal1">[4]</xref>, <xref ref-type="bibr" rid="pone.0018948-Masanjala1">[5]</xref>.</p><p>In the context of HIV/AIDS, there has been growing recognition that the various aspects of livelihoods that increase risk of illness and death need to be identified <xref ref-type="bibr" rid="pone.0018948-Drimie1">[1]</xref>. Limited livelihood security can lead to engaging in risky behaviours that increase HIV incidence <xref ref-type="bibr" rid="pone.0018948-Masanjala1">[5]</xref>. Among those receiving ARVs, limited livelihoods can reduce adherence, create adverse gastrointestinal and other adverse events due to poor diets, and lead to disrupted medication supplies <xref ref-type="bibr" rid="pone.0018948-Drimie1">[1]</xref>, <xref ref-type="bibr" rid="pone.0018948-Masanjala1">[5]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Ellis1">[7]</xref>.</p><p>Highly active antiretroviral therapy (HAART) provides the hope that people living with HIV/AIDS (PLWHA) can now live longer <xref ref-type="bibr" rid="pone.0018948-Hogg1">[8]</xref>, <xref ref-type="bibr" rid="pone.0018948-Mannheimer1">[9]</xref> and more productive lives. Nevertheless, as of 2008, only 42&#x00025; of clinically eligible individuals in LIMC were receiving treatment <xref ref-type="bibr" rid="pone.0018948-Joint1">[10]</xref>, despite the fact that treatment has been recognized as an essential tool for mitigating the impacts of HIV on affected communities <xref ref-type="bibr" rid="pone.0018948-Gavian1">[11]</xref>. Treatment efficacy with ARVs relies on sustained adherence, critical for viral suppression and the prevention of resistance, disease progression, and death <xref ref-type="bibr" rid="pone.0018948-Bangsberg1">[12]</xref>, <xref ref-type="bibr" rid="pone.0018948-Wood1">[13]</xref>. Unfortunately, adherence remains a challenge for many <xref ref-type="bibr" rid="pone.0018948-Mills1">[14]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Altice1">[16]</xref>, given obstacles such as dosing schedules, dietary requirements, and adverse effects <xref ref-type="bibr" rid="pone.0018948-Mills2">[15]</xref>, <xref ref-type="bibr" rid="pone.0018948-Loevinsohn1">[17]</xref>.</p><p>Since the rapid scale-up of ARVs in resource-limited settings, numerous studies have focused on treatment adherence <xref ref-type="bibr" rid="pone.0018948-Mills1">[14]</xref>, <xref ref-type="bibr" rid="pone.0018948-Mills2">[15]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ivers1">[18]</xref>. In 2006, we previously reviewed facilitators and barriers to adherence in developed and developing nations, some of which were livelihood-related (e.g., cost, available social support). However, our review was limited in its ability to directly measure the associations between identified factors and adherence levels <xref ref-type="bibr" rid="pone.0018948-Mills2">[15]</xref>. There remain important gaps in our understanding of the relationship between livelihood security and adherence to ARVs, specifically in the context of treatment sustenance. The objective of our review is to evaluate the adherence literature specifically focused on the role of livelihood security on adherence to ARVs in LMIC.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Inclusion Criteria</title><p>We aimed to include all observational studies that examined the association between financial, human, and social capital, as important indicators of livelihood security, and adherence to ARVs in LMIC settings.</p></sec><sec id="s2b"><title>Ethics</title><p>Ethical approval was not sought for this systematic review as only published data was included. Furthermore, no personal identifiers from patients described in included studies were included. Therefore, written consent from such patients was neither sought nor needed.</p></sec><sec id="s2c"><title>Search Strategy</title><p>We searched the following databases: AMED (inception to January 2010), Campbell Collaboration (inception to January 2010), CinAhl (inception to January 2010), CAB Abstracts (inception to January 2010), Cochrane Library (inception to January 2010), Embase (inception to January 2010), and PubMed via Medline (inception to January 2010). Conference abstracts from the International AIDS Society conferences (inception to 2009) and Conferences on Retroviruses and Opportunistic Infections (inception to 2009) were also sought.</p><p>Our search strategies combined terms that represented livelihood security and HIV. An initial scan of the literature noted that the majority of potentially relevant studies focused on financial, human, and/or social forms of capital. While the role of natural and physical capital was referred to in the qualitative literature, their association with adherence were infrequently estimated. Therefore, in the present study, we focused solely on financial, human, and social types of capital. Using the UK Department of International Development (DFID) Sustainable Livelihood Framework as a guideline <xref ref-type="bibr" rid="pone.0018948-UK1">[19]</xref>, financial capital in the present study denotes access to financial resources; human capital encompasses skills, knowledge, the ability to work, and nutritional factors; and social capital refers to formal and informal social relationships.</p><p>As we were interested in the interaction between adherence and antiretroviral therapy, HIV and livelihoods, our search strategy combined terms representing &#x0201c;HIV OR AIDS&#x0201d; AND &#x0201c;adherence to antiretroviral therapy&#x0201d; AND &#x0201c;financial capital OR human capital OR social capital&#x0201d;. We supplemented this search by reviewing the bibliographies of key papers. As the PRISMA Guidelines for Meta-Analyses and MOOSE guidelines for Systematic Reviews of Observational Studies <xref ref-type="bibr" rid="pone.0018948-Stroup1">[20]</xref> suggest that observational studies are often not indexed well, we did not limit our search by study design.</p></sec><sec id="s2d"><title>Study selection</title><p>BR and DCC independently reviewed the abstracts. Initially, eligible studies met the following criteria: (1) reported an original research study; (2) measured adherence to antiretroviral therapy; (3) contained content addressing the association between social, human, or financial capital and adherence to antiretroviral therapy; and (4) was set in a low-income or middle-income country as defined by the World Bank Country Classification <xref ref-type="bibr" rid="pone.0018948-World1">[21]</xref>. The relevant qualitative studies, though useful with discussions on the contribution of livelihood factors, could not contribute information on the estimate of the association between the livelihood measures of interest and adherence, and, as a result, were excluded.</p></sec><sec id="s2e"><title>Quality Assessment</title><p>We extracted data on the quality of included studies using criteria consolidated from existing critical appraisal sources <xref ref-type="bibr" rid="pone.0018948-Mills1">[14]</xref>, <xref ref-type="bibr" rid="pone.0018948-Katrak1">[22]</xref>, <xref ref-type="bibr" rid="pone.0018948-VonElm1">[23]</xref>. As many studies were clinical case series, with populations of patients being asked additional questions during regular visits, some criteria relevant for more traditional population surveys were not helpful for our assessment (e.g., representativeness of population, use of random selection). For longitudinal studies we added criteria with respect to follow-up: 1) the proportion followed at each stage of the study was described-(e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed) and 2) participants reasons for non-participation at each follow-up were presented <xref ref-type="bibr" rid="pone.0018948-VonElm1">[23]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Public1">[25]</xref>. Conference abstracts usually did not contain sufficient information upon which to conduct quality assessments. Given the limited number of available studies and our interest in exploring the association of livelihood and adherence in a range of LMIC, we chose not to exclude any study based on quality.</p></sec><sec id="s2f"><title>Data Abstraction</title><p>When the full-text of an abstract was not available or when information was not available in the full-text paper, we contacted the study authors for additional information. BR initially appraised quality and content and abstracted relevant data. DCC acted as a secondary reviewer. When disagreement occurred we reached consensus through discussion. The reviewers discussed the studies including characterization of different livelihood measures reported, the strengths of different adherence measures, and the patterns of findings encountered. In addition to descriptive material, we abstracted data on prevalence e.g. of other livelihood factors associated with adherence, and the types and magnitudes of associations e.g. of education with adherence, reported in each study.</p></sec><sec id="s2g"><title>Quantitative Data Synthesis</title><p>Studies were organized and sorted by year of publication, by study design, by sample size, by response rate, and by the livelihood measures examined. The prevalence of various livelihood measures were determined and the proportion of participants reporting each livelihood factor was also captured from individual studies. Patterns across studies were then examined with respect to the estimates of the given associations as well as the precision around these estimates. While few studies consistently measured the same independent (i.e. livelihood) factors and dependent variable (i.e. adherence) we chose to run three separate meta-regressions for each type of livelihood measure (financial, human, social) as a predictor to determine if there were individual effects on adherence levels. Analyses were performed in STATA. A p-value of less than 0.05 was considered statistically significant.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Study Selection and Characteristics</title><p>The initial literature search produced 1209 papers and 469 conference titles and abstracts. There was near perfect agreement between BR and DCC on choosing the potentially relevant 42 papers and 21 abstracts from this larger set. Of these, 20 papers <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref> and 6 conference abstracts <xref ref-type="bibr" rid="pone.0018948-Dahab1">[46]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Sidle1">[51]</xref> were judged relevant for our review (See <xref ref-type="fig" rid="pone-0018948-g001">Figure 1</xref>). There was perfect agreement on the final papers and abstracts selected (kappa&#x0200a;=&#x0200a;1). All were published in English. The majority of included papers initially were identified in PubMed via Medline (n&#x0200a;=&#x0200a;15, 75&#x00025;) <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Iliyasu1">[30]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nemes1">[33]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref>, <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>. Of the remaining 5 papers, 4 were from Embase <xref ref-type="bibr" rid="pone.0018948-Malangu1">[31]</xref>, <xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref> and one was identified from the CAB Abstracts database <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>. All included abstracts were identified through the International AIDS Society conference abstract database.</p><fig id="pone-0018948-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.g001</object-id><label>Figure 1</label><caption><title>Flow Chart of Studies Included in Review.</title></caption><graphic xlink:href="pone.0018948.g001"/></fig><p>All included papers and abstracts employed a quantitative methodology and used structured questionnaires (n&#x0200a;=&#x0200a;8) <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref>, <xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref>, <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>, <xref ref-type="bibr" rid="pone.0018948-Warley1">[48]</xref>, <xref ref-type="bibr" rid="pone.0018948-Darder1">[50]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sidle1">[51]</xref> or structured interviews (n&#x0200a;=&#x0200a;18) <xref ref-type="bibr" rid="pone.0018948-Boyer1">[27]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>, <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>, <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>, <xref ref-type="bibr" rid="pone.0018948-Dahab1">[46]</xref>, <xref ref-type="bibr" rid="pone.0018948-Shah1">[47]</xref>. Seventeen of the papers <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref> and 3 of the conference abstracts <xref ref-type="bibr" rid="pone.0018948-Dahab1">[46]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Warley1">[48]</xref> were cross-sectional studies and 3 papers <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref> and 3 abstracts <xref ref-type="bibr" rid="pone.0018948-Abah1">[49]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Sidle1">[51]</xref> were longitudinal studies, following up patients over time. Almost all studies (n&#x0200a;=&#x0200a;19) used logistic regression analysis to measure the association between livelihoods and adherence. One study <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref> used Cox's proportional hazards to assess the relative hazard of non-adherence. Although detailed information on the nature of statistical analysis was poorly described, all abstracts reported conducting multivariable analysis.</p></sec><sec id="s3b"><title>Quality Assessment</title><p><xref ref-type="table" rid="pone-0018948-t001">Tables 1</xref> and <xref ref-type="table" rid="pone-0018948-t002">2</xref> display the quality criteria results. There was no improvement in quality over time and no studies reported contacting non-responders. The proportion of studies meeting our quality criteria ranged from 0&#x02013;100&#x00025;.</p><table-wrap id="pone-0018948-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.t001</object-id><label>Table 1</label><caption><title>Quality Criteria for included cross-sectional studies [n&#x0200a;=&#x0200a;17, (26&#x02013;42)].</title></caption><alternatives><graphic id="pone-0018948-t001-1" xlink:href="pone.0018948.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Describe setting, time period</td><td align="left" rowspan="1" colspan="1">Include eligibility criteria, sources, selection</td><td align="left" rowspan="1" colspan="1">Include sample size calculations</td><td align="left" rowspan="1" colspan="1">Include and describe response rates</td><td align="left" rowspan="1" colspan="1">Describe variables outcomes, exposures, covariates</td><td align="left" rowspan="1" colspan="1">Describe data sources, measures</td><td align="left" rowspan="1" colspan="1">Survey pre-tested</td><td align="left" rowspan="1" colspan="1">Survey tool tested for validity</td><td align="left" rowspan="1" colspan="1">Describe consent process, ethics approval</td><td align="left" rowspan="1" colspan="1">Train interviewer</td><td align="left" rowspan="1" colspan="1">Translate survey tool</td><td align="left" rowspan="1" colspan="1">Describe analysis</td><td align="left" rowspan="1" colspan="1">Include participant descriptions</td><td align="left" rowspan="1" colspan="1">Include events or outcome measures</td><td align="left" rowspan="1" colspan="1">Main results: include un-adjusted and adjusted results</td><td align="left" rowspan="1" colspan="1">Main results- describe adjustment</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Aboubacrine/2007</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Boyer/2009</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Byakika-Tusiime/2005</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Carlucci/2008</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Iliyasu/2005</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Malangu/2008</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Nachega/2004</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Nemes/2007</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Pinheiro/2002</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Ramadhani/2007</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Sarna/2008</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Silva/2009</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Stout/2004</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Uzochukwu/2009</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Wang/2007</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Weiser/2003</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Williams/2007</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">TOTAL/17</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">8</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone-0018948-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.t002</object-id><label>Table 2</label><caption><title>Quality Criteria for included longitudinal studies [n&#x0200a;=&#x0200a;3, (43&#x02013;45)].</title></caption><alternatives><graphic id="pone-0018948-t002-2" xlink:href="pone.0018948.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Describe setting, time periods</td><td align="left" rowspan="1" colspan="1">Describe eligibility criteria, sources, methods of selection, methods of follow-up</td><td align="left" rowspan="1" colspan="1">Include sample size calculations</td><td align="left" rowspan="1" colspan="1">Include and describe response rate</td><td align="left" rowspan="1" colspan="1">Describe variables-outcomes, exposures, covariates</td><td align="left" rowspan="1" colspan="1">Describe data sources, survey tool</td><td align="left" rowspan="1" colspan="1">Survey pre-tested</td><td align="left" rowspan="1" colspan="1">Survey tested for validity</td><td align="left" rowspan="1" colspan="1">Describe consent process, ethics approval</td><td align="left" rowspan="1" colspan="1">Train interviewer</td><td align="left" rowspan="1" colspan="1">Translate survey tool</td><td align="left" rowspan="1" colspan="1">Describe analysis</td><td align="left" rowspan="1" colspan="1">Describe proportion followed at each stage</td><td align="left" rowspan="1" colspan="1">Include reasons for drop out at each follow-up</td><td align="left" rowspan="1" colspan="1">Include participant description</td><td align="left" rowspan="1" colspan="1">Include events or outcome measure</td><td align="left" rowspan="1" colspan="1">Main results-Include un-adjusted and adjusted results</td><td align="left" rowspan="1" colspan="1">Main results-describe adjusted</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Bonolo/2005</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Erah/2008</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Orrell/2003</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td><td align="left" rowspan="1" colspan="1">&#x0221a;</td></tr><tr><td align="left" rowspan="1" colspan="1">Total/3</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">2</td></tr></tbody></table></alternatives></table-wrap><p>All cross-sectional studies adequately described the setting, variables included, and data measurement sources, and provided descriptive characteristics of included participants. Ten studies (58.9&#x00025;) noted use of a previously validated survey <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>, but few studies reported pre-testing their survey instrument (n&#x0200a;=&#x0200a;5, 29.4&#x00025;) <xref ref-type="bibr" rid="pone.0018948-Iliyasu1">[30]</xref>, <xref ref-type="bibr" rid="pone.0018948-Malangu1">[31]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>. Nine (52.9&#x00025;) studies reported both unadjusted and adjusted estimates <xref ref-type="bibr" rid="pone.0018948-Boyer1">[27]</xref>, <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nemes1">[33]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref> and eight (47.1&#x00025;) justified the inclusion of any covariates <xref ref-type="bibr" rid="pone.0018948-Boyer1">[27]</xref>, <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nemes1">[33]</xref>, <xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref> (no studies reported stratification so we only assessed the use of adjustment).</p><p>All longitudinal studies described the study setting, the populations sampled, the variables and data measurement sources used, provided information on informed consent, provided descriptive characteristics of participants, and provided data on outcome events and summary measures. One study used a previously validated questionnaire <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref> yet none of the two studies conducting interviews provided details on whether the interviewer had been trained. Only one study provided detail on the follow-up of participants and the reasons for losses-to-follow-up <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>. Two studies (66.7&#x00025;) reported unadjusted and adjusted estimates and also justified their inclusion of covariates <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>, <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>.</p></sec><sec id="s3c"><title>Settings and Populations (<xref ref-type="table" rid="pone-0018948-t003">Tables 3</xref> and <xref ref-type="table" rid="pone-0018948-t004">4</xref>)</title><table-wrap id="pone-0018948-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.t003</object-id><label>Table 3</label><caption><title>Characteristics of included cross-sectional papers [n&#x0200a;=&#x0200a;17, (26&#x02013;42)] and conference abstracts [n&#x0200a;=&#x0200a;3, (46&#x02013;48)].</title></caption><alternatives><graphic id="pone-0018948-t003-3" xlink:href="pone.0018948.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Author</td><td align="left" rowspan="1" colspan="1">Yr</td><td align="left" rowspan="1" colspan="1">Country</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">Setting</td><td align="left" rowspan="1" colspan="1">Female (&#x00025;)</td><td align="left" rowspan="1" colspan="1">Median Age, y</td><td align="left" rowspan="1" colspan="1">Response Rate</td><td align="left" rowspan="1" colspan="1">Assessor</td><td align="left" rowspan="1" colspan="1">Adherence, &#x00025; threshold for measurement</td><td align="left" rowspan="1" colspan="1">Adherence Proportion (&#x00025;)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Aboubacrine</bold></td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">Mali, Burkina Faso</td><td align="left" rowspan="1" colspan="1">270</td><td align="left" rowspan="1" colspan="1">Public hospital, community based clinics</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1">36&#x02013;40 (median range)</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">less than 100&#x00025;, no. doses missed in past 7 days</td><td align="left" rowspan="1" colspan="1">58.5</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Boyer</bold></td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">Cameroon</td><td align="left" rowspan="1" colspan="1">532</td><td align="left" rowspan="1" colspan="1">Public hospital</td><td align="left" rowspan="1" colspan="1">70.9</td><td align="left" rowspan="1" colspan="1">mean (SD): 38 (9)</td><td align="left" rowspan="1" colspan="1">83.9</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">high, moderate, low score in past 4 days</td><td align="left" rowspan="1" colspan="1">56.6</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Byakika-Tusiime</bold></td><td align="left" rowspan="1" colspan="1">2005</td><td align="left" rowspan="1" colspan="1">Uganda</td><td align="left" rowspan="1" colspan="1">304</td><td align="left" rowspan="1" colspan="1">ARV delivery centres</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">unknown</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95&#x00025;, No. doses taken/no.prescribed in last 3 days</td><td align="left" rowspan="1" colspan="1">68</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Carlucci</bold></td><td align="left" rowspan="1" colspan="1">2008</td><td align="left" rowspan="1" colspan="1">Zambia</td><td align="left" rowspan="1" colspan="1">409</td><td align="left" rowspan="1" colspan="1">Rural mission hospital</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">39 (32&#x02013;47)</td><td align="left" rowspan="1" colspan="1">78.2</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95&#x00025;, No. doses taken/no. doses prescribed for total time</td><td align="left" rowspan="1" colspan="1">83.7</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Iliyasu</bold></td><td align="left" rowspan="1" colspan="1">2005</td><td align="left" rowspan="1" colspan="1">Nigeria</td><td align="left" rowspan="1" colspan="1">263</td><td align="left" rowspan="1" colspan="1">Teaching hospital</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1">36.2 (3.3)</td><td align="left" rowspan="1" colspan="1">94</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95&#x00025;, based on previous 7 days</td><td align="left" rowspan="1" colspan="1">54</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Malangu</bold></td><td align="left" rowspan="1" colspan="1">2008</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">180</td><td align="left" rowspan="1" colspan="1">Hospital</td><td align="left" rowspan="1" colspan="1">68.8</td><td align="left" rowspan="1" colspan="1">36.7 (8.1)</td><td align="left" rowspan="1" colspan="1">63.2</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95&#x00025;, No. doses taken/no. doses in past 7 days</td><td align="left" rowspan="1" colspan="1">57.2</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Nachega</bold></td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">public outpatient clinic</td><td align="left" rowspan="1" colspan="1">77</td><td align="left" rowspan="1" colspan="1">36.1 (10.1)</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95&#x00025;, No. doses taken/no. doses in past 30 days</td><td align="left" rowspan="1" colspan="1">88</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Nemes</bold></td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">1972</td><td align="left" rowspan="1" colspan="1">Health service sites</td><td align="left" rowspan="1" colspan="1">38</td><td align="left" rowspan="1" colspan="1">39.3</td><td align="left" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95&#x00025;, No. doses taken/no. doses in past 3 days</td><td align="left" rowspan="1" colspan="1">75.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Pinheiro</bold></td><td align="left" rowspan="1" colspan="1">2002</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">195</td><td align="left" rowspan="1" colspan="1">Publicly funded specialist clinic</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">35 (17&#x02013;67)</td><td align="left" rowspan="1" colspan="1">84</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95&#x00025;, No. doses taken/no. doses prescribed in past 2 days</td><td align="left" rowspan="1" colspan="1">56.9</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ramadhani</bold></td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">Tanzania</td><td align="left" rowspan="1" colspan="1">150</td><td align="left" rowspan="1" colspan="1">Infectious disease clinic</td><td align="left" rowspan="1" colspan="1">63</td><td align="left" rowspan="1" colspan="1">41 (19&#x02013;69)</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">100, &#x0003e;2 days without dose</td><td align="left" rowspan="1" colspan="1">84</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sarna</bold></td><td align="left" rowspan="1" colspan="1">2008</td><td align="left" rowspan="1" colspan="1">India</td><td align="left" rowspan="1" colspan="1">310</td><td align="left" rowspan="1" colspan="1">Public and private outpatient clinic</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1">36 (23&#x02013;70)</td><td align="left" rowspan="1" colspan="1">96</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;90, no. Doses taken/no. prescribed in past 4 days</td><td align="left" rowspan="1" colspan="1">84</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Silva</bold></td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">412</td><td align="left" rowspan="1" colspan="1">Clinics at referral hospital</td><td align="left" rowspan="1" colspan="1">21.8</td><td align="left" rowspan="1" colspan="1">36 (17&#x02013;67)</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;90, no. Doses taken/no. prescribed in past 5 days</td><td align="left" rowspan="1" colspan="1">74.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Stout</bold></td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">Costa Rica</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">Social security hospital</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">38.2 (18&#x02013;79)</td><td align="left" rowspan="1" colspan="1">87</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">100, no. Doses taken/no. prescribed past 3 days</td><td align="left" rowspan="1" colspan="1">85</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Uzochukwu</bold></td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">Nigeria</td><td align="left" rowspan="1" colspan="1">174</td><td align="left" rowspan="1" colspan="1">Teaching hospital</td><td align="left" rowspan="1" colspan="1">37.5</td><td align="left" rowspan="1" colspan="1">34.6 (7.2)</td><td align="left" rowspan="1" colspan="1">95.6</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">100, miss at least 1 dose in past 30 days</td><td align="left" rowspan="1" colspan="1">25</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Wang</bold></td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">China</td><td align="left" rowspan="1" colspan="1">181</td><td align="left" rowspan="1" colspan="1">Clinic</td><td align="left" rowspan="1" colspan="1">59.7</td><td align="left" rowspan="1" colspan="1">47.8 (11.3)</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95, no. Doses taken/no. Doses prescribed past 3 days</td><td align="left" rowspan="1" colspan="1">81.8</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Weiser</bold></td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">Botswana</td><td align="left" rowspan="1" colspan="1">109</td><td align="left" rowspan="1" colspan="1">Private clinic</td><td align="left" rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">Not available</td><td align="left" rowspan="1" colspan="1">97.3</td><td align="left" rowspan="1" colspan="1">patient or clinician</td><td align="left" rowspan="1" colspan="1">&#x02265;95, previous year of missing &#x0003c; 1 dose in 10day period or 1 dose/week</td><td align="left" rowspan="1" colspan="1">54</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Williams</bold></td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">West Indies</td><td align="left" rowspan="1" colspan="1">96</td><td align="left" rowspan="1" colspan="1">Clinic</td><td align="left" rowspan="1" colspan="1">54.2</td><td align="left" rowspan="1" colspan="1">35.6</td><td align="left" rowspan="1" colspan="1">95</td><td align="left" rowspan="1" colspan="1">patient or provider</td><td align="left" rowspan="1" colspan="1">&#x02265;95, no. Doses taken/no. prescribed in past 7 days</td><td align="left" rowspan="1" colspan="1">87.7-patient, 87.0-provider</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Abstracts</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dahab</bold></td><td align="left" rowspan="1" colspan="1">2006</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">69</td><td align="left" rowspan="1" colspan="1">Workplace ART programme</td><td align="left" rowspan="1" colspan="1">1&#x00025;</td><td align="left" rowspan="1" colspan="1">43.1</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x0003c;1 log drop in viral load at 6 weeks after treatment start</td><td align="left" rowspan="1" colspan="1">86</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Shah</bold></td><td align="left" rowspan="1" colspan="1">2006</td><td align="left" rowspan="1" colspan="1">India</td><td align="left" rowspan="1" colspan="1">279</td><td align="left" rowspan="1" colspan="1">Private clinic</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x0003e;95, doses missed in past 4 days</td><td align="left" rowspan="1" colspan="1">73</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Warley</bold></td><td align="left" rowspan="1" colspan="1">2006</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">clinic</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">37.9</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x0003e;95, doses missed in past 4 days</td><td align="left" rowspan="1" colspan="1">70.4</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Summary (median, range)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>51.5 (1</bold>&#x02013;<bold>77)</bold></td><td align="left" rowspan="1" colspan="1"><bold>37.9 (34.6</bold>&#x02013;<bold>47.8)</bold></td><td align="left" rowspan="1" colspan="1"><bold>95 (63.2</bold>&#x02013;<bold>100)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>73.6 (25</bold>&#x02013;<bold>88)</bold></td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone-0018948-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.t004</object-id><label>Table 4</label><caption><title>Characteristics of included longitudinal papers [n&#x0200a;=&#x0200a;3, (43&#x02013;45)] and conference abstracts [n&#x0200a;=&#x0200a;3, (49&#x02013;51)].</title></caption><alternatives><graphic id="pone-0018948-t004-4" xlink:href="pone.0018948.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Author</td><td align="left" rowspan="1" colspan="1">Year</td><td align="left" rowspan="1" colspan="1">Country</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">Setting</td><td align="left" rowspan="1" colspan="1">Female (&#x00025;)</td><td align="left" rowspan="1" colspan="1">Median Age, y</td><td align="left" rowspan="1" colspan="1">Response Rate</td><td align="left" rowspan="1" colspan="1">Follow-up (FU)</td><td align="left" rowspan="1" colspan="1">Assessor</td><td align="left" rowspan="1" colspan="1">Adherence, &#x00025; threshold for measurement</td><td align="left" rowspan="1" colspan="1">Adherence Proportion (&#x00025;)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Bonolo</bold></td><td align="left" rowspan="1" colspan="1">2005</td><td align="left" rowspan="1" colspan="1">Brazil</td><td align="left" rowspan="1" colspan="1">306</td><td align="left" rowspan="1" colspan="1">Public referral hospital</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">35</td><td align="left" rowspan="1" colspan="1">73.4&#x00025;</td><td align="left" rowspan="1" colspan="1">Median overall FU time: 247 days</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95&#x00025;, number doses taken in past 3 days</td><td align="left" rowspan="1" colspan="1">cumulative: 36.9&#x00025;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Erah</bold></td><td align="left" rowspan="1" colspan="1">2008</td><td align="left" rowspan="1" colspan="1">Nigeria</td><td align="left" rowspan="1" colspan="1">102</td><td align="left" rowspan="1" colspan="1">HIV treatment centre</td><td align="left" rowspan="1" colspan="1">64</td><td align="left" rowspan="1" colspan="1">mean: 36.3 (7.9)</td><td align="left" rowspan="1" colspan="1">81.6</td><td align="left" rowspan="1" colspan="1">Unknown</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95&#x00025;, number doses taken in past 30 d</td><td align="left" rowspan="1" colspan="1">58.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Orrell</bold></td><td align="left" rowspan="1" colspan="1">2003</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">289</td><td align="left" rowspan="1" colspan="1">University HIV clinic</td><td align="left" rowspan="1" colspan="1">43</td><td align="left" rowspan="1" colspan="1">33.4 (8.7)</td><td align="left" rowspan="1" colspan="1">96.2</td><td align="left" rowspan="1" colspan="1">87.5&#x00025; after 4 wk; 83.7&#x00025; after 48 wk</td><td align="left" rowspan="1" colspan="1">pharmacy refill and pill count</td><td align="left" rowspan="1" colspan="1">&#x02265;90, medication dispensed minus pills returned/no. Pills prescribed over 48 weeks</td><td align="left" rowspan="1" colspan="1">63</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Abstracts</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Abah</bold></td><td align="left" rowspan="1" colspan="1">2006</td><td align="left" rowspan="1" colspan="1">Nigeria</td><td align="left" rowspan="1" colspan="1">130</td><td align="left" rowspan="1" colspan="1">Teaching hospital</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">patient and pharmacy</td><td align="left" rowspan="1" colspan="1">&#x02265;95, &#x00025; of doses prescribed over 6 month period</td><td align="left" rowspan="1" colspan="1">85.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Darder</bold></td><td align="left" rowspan="1" colspan="1">2004</td><td align="left" rowspan="1" colspan="1">South Africa</td><td align="left" rowspan="1" colspan="1">192</td><td align="left" rowspan="1" colspan="1">Clinic</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">&#x02265;95, &#x00025; of doses</td><td align="left" rowspan="1" colspan="1">88</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sidle</bold></td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">Kenya</td><td align="left" rowspan="1" colspan="1">7381</td><td align="left" rowspan="1" colspan="1">clinics</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">patient</td><td align="left" rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">77</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Summary (median, range)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>43 (35</bold>&#x02013;<bold>64)</bold></td><td align="left" rowspan="1" colspan="1"><bold>35 (33.4</bold>&#x02013;<bold>36.3)</bold></td><td align="left" rowspan="1" colspan="1"><bold>81.6 (73</bold>&#x02013;<bold>96.2)</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>N/A: Not Available.</p></fn></table-wrap-foot></table-wrap><p>Sixteen studies (13 papers, 3 abstracts) were conducted in Africa <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>, <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>, <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>, <xref ref-type="bibr" rid="pone.0018948-Dahab1">[46]</xref>, <xref ref-type="bibr" rid="pone.0018948-Abah1">[49]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Sidle1">[51]</xref>. Seven studies (6 papers, 1 abstract) were conducted in Central and South America <xref ref-type="bibr" rid="pone.0018948-Nemes1">[33]</xref>, <xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref>, <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref>, <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>, <xref ref-type="bibr" rid="pone.0018948-Warley1">[48]</xref>, with the majority in Brazil <xref ref-type="bibr" rid="pone.0018948-Nemes1">[33]</xref>, <xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref>, <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>, <xref ref-type="bibr" rid="pone.0018948-Warley1">[48]</xref>. Two studies (1 paper, 1 abstract) <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Shah1">[47]</xref> were conducted in India and 1 study in China <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>. Since the most recent systematic review which examined factors affecting adherence <xref ref-type="bibr" rid="pone.0018948-Mills2">[15]</xref>, eleven cross-sectional (64.7&#x00025;) <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref>, <xref ref-type="bibr" rid="pone.0018948-Boyer1">[27]</xref>, <xref ref-type="bibr" rid="pone.0018948-Carlucci1">[29]</xref>, <xref ref-type="bibr" rid="pone.0018948-Malangu1">[31]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>, <xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref> and 2 longitudinal studies (66.7&#x00025;) have been published <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sidle1">[51]</xref>.</p><p>Included studies reflect a diverse range of settings and study populations. Studies were conducted primarily in public, teaching, or referral hospitals (n&#x0200a;=&#x0200a;9), public outpatient or community-based clinics (n&#x0200a;=&#x0200a;10), and specialist/HIV clinics or treatment centres (n&#x0200a;=&#x0200a;6), although private clinics (n&#x0200a;=&#x0200a;3) and a workplace ARV programme (n&#x0200a;=&#x0200a;1) were also reported. The proportion of women included in cross-sectional studies ranged from 1&#x02013;77&#x00025; (median 51.5&#x00025;) and between 35&#x02013;64&#x00025; (median 43&#x00025;) in longitudinal studies. The median age was 37.9 and 35 for participants in cross-sectional and longitudinal studies respectively. The response rate was unknown for 4 cross-sectional papers <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref> and all conference abstracts.</p></sec><sec id="s3d"><title>Adherence Threshold Measurements</title><p>Twenty-two studies (84.6&#x00025;) assessed adherence using patient-reported adherence levels over a specified period. One study used pharmacy claims and three used a combination of patient and clinician/provider assessment. Twelve papers <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref>, <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>, <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref> and 4 abstracts <xref ref-type="bibr" rid="pone.0018948-Shah1">[47]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Darder1">[50]</xref> defined adherence as greater or equal than 95&#x00025; during the measurement period, which ranged from 2 days to 6 months. Five studies <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sidle1">[51]</xref> defined adherence as being 100&#x00025; during the measurement period. Three studies <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref>, <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref> assessed adherence as greater than 90&#x00025; over the measurement period. Median adherence proportions in cross-sectional studies were 74.3&#x00025; (Range 25&#x02013;88&#x00025;) for papers alone and 73.6&#x00025; when the three conference abstracts were added. While the median adherence levels among the 3 longitudinal studies were 58.1&#x00025;, it increased to 70&#x00025; when the three conference abstracts were added. Overall range differed little from the cross-sectional studies (36.9&#x02013;88&#x00025;).</p></sec><sec id="s3e"><title>Financial, Human, and Social Capital Factors Affecting Adherence: (<xref ref-type="table" rid="pone-0018948-t005">Tables 5</xref>&#x02013;<xref ref-type="table" rid="pone-0018948-t006"/><xref ref-type="table" rid="pone-0018948-t007"/><xref ref-type="table" rid="pone-0018948-t008"/><xref ref-type="table" rid="pone-0018948-t009">9</xref>)</title><table-wrap id="pone-0018948-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.t005</object-id><label>Table 5</label><caption><title>Financial, Human, Social Capital factors associated<xref ref-type="table-fn" rid="nt102">&#x0002a;</xref> with adherence or non-adherence to antiretroviral therapy in included cross-sectional papers [n&#x0200a;=&#x0200a;7, (26&#x02013;32)].</title></caption><alternatives><graphic id="pone-0018948-t005-5" xlink:href="pone.0018948.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Financial Capital</td><td colspan="3" align="left" rowspan="1">Human Capital</td><td colspan="4" align="left" rowspan="1">Social Capital</td><td align="left" rowspan="1" colspan="1">Other</td></tr><tr><td align="left" rowspan="1" colspan="1">Author/Year</td><td align="left" rowspan="1" colspan="1">Financial constraints/ARV payment</td><td align="left" rowspan="1" colspan="1">Household Income</td><td align="left" rowspan="1" colspan="1">Distance to clinic/transport costs</td><td align="left" rowspan="1" colspan="1">Education</td><td align="left" rowspan="1" colspan="1">Employment Status</td><td align="left" rowspan="1" colspan="1">Food-related restrictions</td><td align="left" rowspan="1" colspan="1">Marital Status</td><td align="left" rowspan="1" colspan="1">Household size</td><td align="left" rowspan="1" colspan="1">Social support</td><td align="left" rowspan="1" colspan="1">Fear of Stigma/non-disclosure</td><td align="left" rowspan="1" colspan="1">Reasons for missing doses</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Aboubacrine/2007</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">work with no stable salary vs. no work associated with adherence: OR: 3.15 (1.15&#x02013;11.13)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Having children vs. not associated with adherence OR: 2.36 (1.08&#x02013;5.15)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Boyer/2005</bold></td><td align="left" rowspan="1" colspan="1">Difficulty buying ARV and reporting high adherence: OR: 0.24 (0.15&#x02013;0.4)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Byakika-Tusiime/2005</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Monthly &#x0003c; $US 50 associated with non-adherence 0R: 2.42 (1.24&#x02013;4.0), AOR: 2.77 (1.64&#x02013;4.67)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Education level attained, ns</td><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">being single associated with non-adherence: OR: 1.19 (0.73&#x02013;1.95) AOR: 2.93 (1.32&#x02013;6.5)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">lack of money (72.4&#x00025;), away from home (11.2&#x00025;)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Carlucci/2008</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Travel duration: ns Transport cost: ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Stigma vs. none, ns</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Iliyasu/2005</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">formal vs. no formal education associated with adherence: OR: 3.97 (1.75&#x02013;9.24)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">lack of funds (15.8&#x00025;)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Malangu/2008</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Having a tertiary education vs. other, ns</td><td align="left" rowspan="1" colspan="1">Being employed vs. other, ns</td><td align="left" rowspan="1" colspan="1">Eating well associated with adherence (p&#x0200a;=&#x0200a;0.03)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Away from home (15.6&#x00025;)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Nachega/2004</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ns</td><td align="left" rowspan="1" colspan="1">Being employed vs. unemployed: ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Fear of stigma from partner vs. no associated with adherence OR: 0.13 (0.02&#x02013;0.70)</td><td align="left" rowspan="1" colspan="1">being away (30&#x00025;), stigma (75&#x00025;)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt102"><label/><p>&#x0002a;OR: Odds Ratio, AOR: Adjusted Odds Ratio, (n<sub>1</sub>&#x02013;n<sub>2</sub>): 95&#x00025; Confidence Intervals, sig: significant, ns: not significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0018948-t006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.t006</object-id><label>Table 6</label><caption><title>Financial, Human, Social Capital factors associated<xref ref-type="table-fn" rid="nt103">&#x0002a;</xref> with adherence or non-adherence to antiretroviral therapy in included cross-sectional papers [n&#x0200a;=&#x0200a;4, (33&#x02013;36)].</title></caption><alternatives><graphic id="pone-0018948-t006-6" xlink:href="pone.0018948.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Financial Capital</td><td colspan="3" align="left" rowspan="1">Human Capital</td><td colspan="4" align="left" rowspan="1">Social Capital</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Author/Year</td><td align="left" rowspan="1" colspan="1">Financial constraints/ARV payment</td><td align="left" rowspan="1" colspan="1">Household Income</td><td align="left" rowspan="1" colspan="1">Distance to clinic/Transport costs</td><td align="left" rowspan="1" colspan="1">Education</td><td align="left" rowspan="1" colspan="1">Employment Status</td><td align="left" rowspan="1" colspan="1">Food-related restrictions</td><td align="left" rowspan="1" colspan="1">Marital Status</td><td align="left" rowspan="1" colspan="1">Household size</td><td align="left" rowspan="1" colspan="1">Social support</td><td align="left" rowspan="1" colspan="1">Fear of Stigma/non-disclosure</td><td align="left" rowspan="1" colspan="1">Reasons for missing doses</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Nemes/2004</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0&#x02013;2 years schooling associated with non-adherence OR: 1.51 (1.12&#x02013;2.02), AOR: 1.48 (1.16&#x02013;1.89)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Pinheiro/2002</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Monthly income, ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02265;8 years of schooling vs. 0&#x02013;4 associated with adherence AOR: 2.26 (1.02&#x02013;5.02)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Ramadhani/2007</bold></td><td align="left" rowspan="1" colspan="1">Paying for treatment associated with non-adherence OR: 4.9 (1.92&#x02013;25.9), AOR: 23.5 (1.2&#x02013;444.4) Sacrifice health for other needs OR: 20.7 (3.9&#x02013;110.3), AOR: 19.8 (3.1&#x02013;127.8)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Walking time to the clinic associated with non-adherence OR: 1.2 (1&#x02013;1.5)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Disclosure of HIV associated with non-adherence OR: 0.23 (0.05&#x02013;1.1), AOR: 0.16 (0.02&#x02013;1.1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sarna/2008</bold></td><td align="left" rowspan="1" colspan="1">free ARV vs. paid out-of- pocket associated with non-adherence: 5.71 (2.94&#x02013;11.10), AOR: 4.05 (1.42&#x02013;11.54)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0003c; 5 years education vs. university associated with non-adherence: OR: 4.28 (1.49&#x02013;12.33), 6&#x02013;12 years, OR: 2.83 (1.29&#x02013;6.19)</td><td align="left" rowspan="1" colspan="1">Unemployed vs. employed associated with non-adherence: OR: 2.35 (1.22&#x02013;4.88). AOR: ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">travel, financial difficulties</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label/><p>&#x0002a;OR: Odds Ratio, AOR: Adjusted Odds Ratio, (n<sub>1</sub>&#x02013;n<sub>2</sub>): 95&#x00025; Confidence Intervals, sig: significant, ns: not significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0018948-t007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.t007</object-id><label>Table 7</label><caption><title>Financial, Human, Social Capital factors associated<xref ref-type="table-fn" rid="nt104">&#x0002a;</xref> with adherence or non-adherence to antiretroviral therapy in included cross-sectional papers [n&#x0200a;=&#x0200a;6, (37&#x02013;42)].</title></caption><alternatives><graphic id="pone-0018948-t007-7" xlink:href="pone.0018948.t007"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Financial Capital</td><td colspan="3" align="left" rowspan="1">Human Capital</td><td colspan="4" align="left" rowspan="1">Social Capital</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Author/Year</td><td align="left" rowspan="1" colspan="1">Financial constraints/ARV payment</td><td align="left" rowspan="1" colspan="1">Household Income</td><td align="left" rowspan="1" colspan="1">Distance to clinic/Transport costs</td><td align="left" rowspan="1" colspan="1">Education</td><td align="left" rowspan="1" colspan="1">Employment Status</td><td align="left" rowspan="1" colspan="1">Food-related restrictions</td><td align="left" rowspan="1" colspan="1">Marital Status</td><td align="left" rowspan="1" colspan="1">Household size</td><td align="left" rowspan="1" colspan="1">Social support</td><td align="left" rowspan="1" colspan="1">Fear of Stigma/non-disclosure</td><td align="left" rowspan="1" colspan="1">Reasons for missing doses</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Silva/2009</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Higher income associated with adherence: p&#x0200a;=&#x0200a;0.08, AOR: 2.33 (1.17&#x02013;4.66)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">8 years of schooling vs. 11 years, ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Stout/2004</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Difficulty finding transport vs. other associated with non-adherence OR: 6.3, (1.5&#x02013;26.9)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Difficulty taking meds on empty stomach vs. other OR: 6.7 (1.3-35.7)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">travel away from home: 17&#x00025;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Uzochukwu/2009</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Ns</td><td align="left" rowspan="1" colspan="1">Living 20&#x0002b;Km associate with adherence, p&#x0200a;=&#x0200a;0.038</td><td align="left" rowspan="1" colspan="1">formal education associated with non-adherence (p&#x0200a;=&#x0200a;0.0394)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">being single associated with non-adherence p&#x0200a;=&#x0200a;0.02</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Cost and transport (30.1&#x00025;), sold drugs because need money (28.2&#x00025;)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Wang/2007</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HIV knowledge associated with adherence OR: 5.59, (2.48&#x02013;12.57), AOR: 3.20, (1.24&#x02013;8.26)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Support as reminder tool associated with adherence: OR: 4.22, (1.90&#x02013;9.39), AOR: 3.49, (1.36&#x02013;8.96)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Community/social activities (16.3), food restrictions (11.2&#x00025;), stigma (14.3&#x00025;)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Weiser/2003</bold></td><td align="left" rowspan="1" colspan="1">Cost as a barrier to treatment associated with adherence: OR: 0.15 (0.06&#x02013;0.35), AOR: 0.11 (0.04&#x02013;0.30)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Incomplete secondary ed compared to complete associated with adherence OR: 3.87 (1.21&#x02013;12.40)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Disclosure to others associated with adherence OR: 3.55 (0.91&#x02013;13.92)</td><td align="left" rowspan="1" colspan="1">Financial difficulties (48&#x00025;), travelling (12&#x00025;), distance to clinic (5&#x00025;), stigma (3&#x00025;)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Williams/2007</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">positive, ns</td><td align="left" rowspan="1" colspan="1">positive, ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">No food, social problems</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><label/><p>&#x0002a;OR: Odds Ratio, AOR: Adjusted Odds Ratio, (n<sub>1</sub>&#x02013;n<sub>2</sub>): 95&#x00025; Confidence Intervals, sig: significant, ns: not significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0018948-t008" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.t008</object-id><label>Table 8</label><caption><title>Financial, Human, Social Capital factors associated<xref ref-type="table-fn" rid="nt105">&#x0002a;</xref> with adherence or non-adherence to antiretroviral therapy in included cross-sectional abstracts [n&#x0200a;=&#x0200a;3, (46&#x02013;48)] and summary of associations in all cross-sectional studies [n&#x0200a;=&#x0200a;20, (26&#x02013;42, 46&#x02013;48)].</title></caption><alternatives><graphic id="pone-0018948-t008-8" xlink:href="pone.0018948.t008"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Financial Capital</td><td colspan="3" align="left" rowspan="1">Human Capital</td><td colspan="4" align="left" rowspan="1">Social Capital</td></tr><tr><td align="left" rowspan="1" colspan="1">Author/Year</td><td align="left" rowspan="1" colspan="1">Financial constraints/ARV payment</td><td align="left" rowspan="1" colspan="1">Household Income</td><td align="left" rowspan="1" colspan="1">Distance to clinic/Transport costs</td><td align="left" rowspan="1" colspan="1">Education</td><td align="left" rowspan="1" colspan="1">Employment Status</td><td align="left" rowspan="1" colspan="1">Food-related restrictions</td><td align="left" rowspan="1" colspan="1">Marital Status</td><td align="left" rowspan="1" colspan="1">Household Size</td><td align="left" rowspan="1" colspan="1">Social Support</td><td align="left" rowspan="1" colspan="1">Fear of stigma/non-disclosure</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Dahab/2006</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Educated vs. other associated with adherence OR: 2.4 (1.2&#x02013;4.7)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Shah/2006</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Positive association, sig.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Fear of stigma, Negative association, sig.</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Warley/2006</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>SUMMARY of associations with adherence across all cross-sectional studies (n&#x0200a;=&#x0200a;20)</bold></td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;4 Positive: 1 Negative: 3</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;5 Positive: 2 No assoc: 3</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;4 Positive:1 Negative:2 No assoc: 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;15 Positive: 7 Negative: 2 No Assoc: 6</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;7 Positive: 2 No Assoc: 5</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;2 Negative:2</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;3 Negative (single): 2 No assoc: 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;1 Positive: 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;3 positive: 1 No assoc: 2</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;5 No Assoc: 1 Positive (disclosure):3 Negative (stigma):1</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt105"><label/><p>&#x0002a;OR: Odds Ratio, AOR: Adjusted Odds Ratio, (n<sub>1</sub>&#x02013;n<sub>2</sub>): 95&#x00025; Confidence Intervals, sig: significant, ns: not significant.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0018948-t009" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0018948.t009</object-id><label>Table 9</label><caption><title>Financial, Human, and Social capital associated<xref ref-type="table-fn" rid="nt106">&#x0002a;</xref> with adherence or non-adherence to antiretroviral therapy in included longitudinal studies and summary of all associations [n&#x0200a;=&#x0200a;6, (43&#x02013;45, 49&#x02013;51)].</title></caption><alternatives><graphic id="pone-0018948-t009-9" xlink:href="pone.0018948.t009"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="3" align="left" rowspan="1">Financial Capital</td><td colspan="3" align="left" rowspan="1">Human Capital</td><td colspan="3" align="left" rowspan="1">Social Capital</td><td align="left" rowspan="1" colspan="1">Other</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Author/Year</bold></td><td align="left" rowspan="1" colspan="1">Financial constraints/payment of ARV</td><td align="left" rowspan="1" colspan="1">Household Income</td><td align="left" rowspan="1" colspan="1">Distance from Clinic</td><td align="left" rowspan="1" colspan="1">Education</td><td align="left" rowspan="1" colspan="1">Employment Status</td><td align="left" rowspan="1" colspan="1">Food-Related Restrictions</td><td align="left" rowspan="1" colspan="1">Marital status</td><td align="left" rowspan="1" colspan="1">Household size</td><td align="left" rowspan="1" colspan="1">Social support</td><td align="left" rowspan="1" colspan="1">Reasons for missing doses:</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Bonolo/2005</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Individual &#x02264;US$80 vs. greater, associated with non-adherence RH: 1.61 (1.08&#x02013;2.39)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02264;4 years school vs. &#x0003e; 8 associated with non-adherence RH: 1.80 (1.08&#x02013;2.29)</td><td align="left" rowspan="1" colspan="1">Unemployed vs. employed associated with non-adherence: RH: 2.16 (1.20&#x02013;3.91), ARH: 2.17 (1.19&#x02013;3.96)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Does not participate in religious activities vs. regular activity associated with non-adherence ARH: 2.27 (1.58&#x02013;3.25)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Erah/2008</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">None or primary education associated with non-adherence OR: 1.81 (1.25&#x02013;2.51), AOR: 2.23 (1.02&#x02013;2.89)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">poor financial status and inadequate family support (15.9&#x00025;), occupational factors (25&#x00025;)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Orrell/2003</bold></td><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Restrictions associated with adherence: ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Abstracts</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Abah/2006</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1">ns</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Married associated with adherence, p&#x0200a;=&#x0200a;0.02</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">lack of money (17.1&#x00025;)</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Darder/2006</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Positively associated with adherence, sig.</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sidle/2007</bold></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Level of education associated non- adherence: AOR: 0.96, p&#x0200a;=&#x0200a;0.0269</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">More children associated adherence, AOR&#x0200a;=&#x0200a;1.19, p&#x0200a;=&#x0200a;0.0352</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Summary of associations with adherence</bold></td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;1, No assoc:1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;2 Positive: 1 No assoc: 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;1, No assoc: 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;5 Positive: 4 No Assoc. : 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;2 Positive: 1 No assoc.: 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;1 No assoc.: 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;1 Positive (married): 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;2 Positive: 1 No Assoc.: 1</td><td align="left" rowspan="1" colspan="1">n&#x0200a;=&#x0200a;1 Positive: 1</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt106"><label/><p>&#x0002a;OR: Odds Ratio, AOR: Adjusted Odds Ratio, RH: Relative Hazard, ARH: Adjusted Relative Hazard.</p></fn></table-wrap-foot></table-wrap><sec id="s3e1"><title>Financial Capital</title><p>Five studies, 4 cross-sectional <xref ref-type="bibr" rid="pone.0018948-Boyer1">[27]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref> and 1 longitudinal <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>, measured the association between financial constraints/ability to pay for treatment and adherence. Two reported lower levels of adherence associated with increasing financial difficulties <xref ref-type="bibr" rid="pone.0018948-Boyer1">[27]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>. One study reported that the need to sacrifice health to pay for other resources such as housing was associated with non-adherence (Odds Ratio (OR): 19.8, 95&#x00025; Confidence Intervals (CI): 3.1&#x02013;122.7) <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>. One study reported that non-adherence was associated with having access to free treatment (OR: 4.05, 95&#x00025; CI: 1.42&#x02013;11.54) <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref> while another reported that the association between financial constraints and adherence was not-significant when examined over time <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>.</p><p>Five cross-sectional <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref> and 2 longitudinal <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>, <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref> studies examined the association between household income and adherence, 4 of which demonstrated a non-significant association <xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>. One study reported an increase in non-adherence associated with a monthly income of &#x0003c;$50 US (Adjusted OR (AOR): 2.77, 95&#x00025; CI: 1.64&#x02013;4.67) <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref> while one cross-sectional and one longitudinal study reported that adherence was associated with an increase in household (AOR: 2.33, 95&#x00025; CI: 1.17&#x02013;4.66) <xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref> or individual income (Relative Hazard (RH): 1.61, 95&#x00025; CI: 1.08&#x02013;2.39) <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>.</p><p>Five studies (4 cross-sectional <xref ref-type="bibr" rid="pone.0018948-Carlucci1">[29]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, 1 longitudinal <xref ref-type="bibr" rid="pone.0018948-Abah1">[49]</xref>) examined how distance from the clinic and the ability to pay for transport impacted adherence. One large study showed a non-significant association <xref ref-type="bibr" rid="pone.0018948-Carlucci1">[29]</xref>. One study demonstrated that living more than 20 km away was positively associated with better adherence <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, while two studies demonstrated a negative association, with non-adherence increasing with distance (OR: 1.2, 95&#x00025; CI 1.0&#x02013;1.5) <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref> or difficulty finding transport (AOR: 6.3, 95&#x00025; CI: 1.5&#x02013;26.9) <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>.</p><p>There was a statistically significant positive association demonstrated between overall financial livelihood and adherence proportions (exponentiated beta coefficient&#x0200a;=&#x0200a; 1.53, 95&#x00025; CI: 1.03&#x02013;2.29, p&#x0200a;=&#x0200a;0.04).</p></sec><sec id="s3e2"><title>Human Capital</title><p>Fifteen cross-sectional <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Iliyasu1">[30]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Silva1">[37]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref>, <xref ref-type="bibr" rid="pone.0018948-Dahab1">[46]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Warley1">[48]</xref>, and five longitudinal <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>, <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>, <xref ref-type="bibr" rid="pone.0018948-Abah1">[49]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Sidle1">[51]</xref> studies examined the association between education and adherence. One study examined HIV knowledge and reported that increasing education and knowledge about HIV was associated with adherence (AOR: 3.20, 95&#x00025; CI: 1.24&#x02013;8.26) <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>. Six cross-sectional <xref ref-type="bibr" rid="pone.0018948-Iliyasu1">[30]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nemes1">[33]</xref>, <xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Dahab1">[46]</xref>, <xref ref-type="bibr" rid="pone.0018948-Shah1">[47]</xref> and four longitudinal studies <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>, <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>, <xref ref-type="bibr" rid="pone.0018948-Darder1">[50]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sidle1">[51]</xref> reported a positive association between education and adherence. Two cross-sectional studies reported a negative association: one reporting that a formal education was associated with non-adherence <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref> and another reporting higher levels of adherence among individuals who had not completed secondary school compared to those who had (OR: 3.87, 1.21&#x02013;12.40) <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>.</p><p>Nine studies, seven cross-sectional <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref>, <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Malangu1">[31]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref>, <xref ref-type="bibr" rid="pone.0018948-Warley1">[48]</xref> and two longitudinal <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>, <xref ref-type="bibr" rid="pone.0018948-Abah1">[49]</xref>, examined the association with employment status. Of these, one cross-sectional <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref> and one longitudinal <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref> study reported a positive and significant association between employment and adherence.</p><p>Three studies, 2 cross-sectional <xref ref-type="bibr" rid="pone.0018948-Malangu1">[31]</xref>, <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref> and one longitudinal <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>, measured the association with food-related restrictions. One study reported that adherence was positively associated with eating well <xref ref-type="bibr" rid="pone.0018948-Malangu1">[31]</xref> while another demonstrated that non-adherence was associated with not having enough food to take with medications (OR: 6.7, 95&#x00025; CI: 1.3&#x02013;35.7) <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>.</p><p>No statistically significant association between human capital and adherence was found (exponentiated beta coefficient&#x0200a;=&#x0200a;1.04, 95&#x00025; CI: 0.71&#x02013;1.53, p&#x0200a;=&#x0200a;0.81).</p></sec><sec id="s3e3"><title>Social Capital</title><p>Four studies (3 cross-sectional <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>, 1 longitudinal <xref ref-type="bibr" rid="pone.0018948-Abah1">[49]</xref>) examined the role of marital status: one study demonstrated that being single was positively associated with adherence (AOR: 2.93, 95&#x00025; CI: 1.32&#x02013;6.5) <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref> while another demonstrated that being single was negatively associated with adherence <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>. Being married was positively associated with adherence in one longitudinal study <xref ref-type="bibr" rid="pone.0018948-Abah1">[49]</xref>.</p><p>One cross-sectional (OR: 2.36, 95&#x00025; CI: 1.08&#x02013;5.15) <xref ref-type="bibr" rid="pone.0018948-Aboubacrine1">[26]</xref> and 1 longitudinal study (AOR: 1.19, p&#x0200a;=&#x0200a;0.0352) <xref ref-type="bibr" rid="pone.0018948-Sidle1">[51]</xref> reported a positive association between household size, specifically the number of children, and adherence.</p><p>Three studies, 3 cross-sectional <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>, <xref ref-type="bibr" rid="pone.0018948-Warley1">[48]</xref> and one longitudinal <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>), examined the role of social support: One study found that using support networks as reminder tools was positively associated with adherence (AOR: 3.49, 95&#x00025; CI: 1.36&#x02013;8.96) <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>. A longitudinal study reported that not participating in any religious activities was associated with non-adherence (Adjusted RH (ARH): 2.27, 95&#x00025; CI: 1.58&#x02013;3.25) <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref>.</p><p>Fear of stigma and disclosure of HIV status was examined in 5 cross-sectional studies <xref ref-type="bibr" rid="pone.0018948-Carlucci1">[29]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>, <xref ref-type="bibr" rid="pone.0018948-Shah1">[47]</xref>. Two studies reported that stigma was negatively associated with adherence to ARVs <xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Shah1">[47]</xref>.</p><p>Overall social livelihood and adherence were positively associated but not significant for this set of studies (exponentiated beta coefficient: 1.79, 95&#x00025; CI: 0.63&#x02013;5.08, p&#x0200a;=&#x0200a;0.21).</p></sec></sec><sec id="s3f"><title>Patient-report reasons for missing doses/non-adherence</title><p>Ten cross-sectional studies <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Iliyasu1">[30]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref> and two longitudinal studies <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>, <xref ref-type="bibr" rid="pone.0018948-Darder1">[50]</xref> reported additional patient-identified barriers to treatment adherence (i.e., reasons for missing doses). Reported barriers included: financial difficulties (n&#x0200a;=&#x0200a;7) <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Iliyasu1">[30]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>, <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>, <xref ref-type="bibr" rid="pone.0018948-Darder1">[50]</xref>, being or travelling away from home (n&#x0200a;=&#x0200a;7) <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Malangu1">[31]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>, fear of stigma (n&#x0200a;=&#x0200a;3) <xref ref-type="bibr" rid="pone.0018948-Nachega1">[32]</xref>, <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>, the need to participate in social activities (n&#x0200a;=&#x0200a;2) <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>, <xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref>, food restrictions (n&#x0200a;=&#x0200a;2) <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>, <xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref>, inadequate family support (n&#x0200a;=&#x0200a;1) <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref> and occupational factors (n&#x0200a;=&#x0200a;1) <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>.</p></sec></sec><sec id="s4"><title>Discussion</title><p>The diversity of studies included in this review and the lack of consistency between them suggests that the literature on livelihood and HIV treatment outcomes is still in its infancy. Studies were conducted in numerous settings and the measurement tools used to assess and define both livelihood factors and adherence varied substantially. Adherence proportions ranged from 25&#x00025; to 88&#x00025; and were tested for associations with ten different livelihood factors related to financial, human, or social capital.</p><p>Education level was the most commonly measured livelihood factor. While almost all studies indicated that a higher level of education was associated with adherence, two studies reported a negative association <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>. Higher levels of education have previously been associated with increased risky behavior and risks of HIV infection <xref ref-type="bibr" rid="pone.0018948-Shelton1">[52]</xref>. The reasons for this remain unclear. Talam et al. (2008) argue that better educated patients may be too busy with their professional activities to take their pills regularly <xref ref-type="bibr" rid="pone.0018948-Talam1">[53]</xref>. In contrast, others have argued that greater access to information as a result of higher education, likely helps individuals to make more informed decisions about the need to remain adherent <xref ref-type="bibr" rid="pone.0018948-Erah1">[44]</xref>, <xref ref-type="bibr" rid="pone.0018948-Nwauche1">[54]</xref>. Higher educated patients may also be better equipped to plan, organize, and integrate new realities into their daily lives <xref ref-type="bibr" rid="pone.0018948-Bandura1">[55]</xref>. Furthermore, education level has also been considered an important determinant of self-efficacy which previously has been positively associated with adherence to ARVs <xref ref-type="bibr" rid="pone.0018948-Pinheiro1">[34]</xref>, <xref ref-type="bibr" rid="pone.0018948-Bandura1">[55]</xref>.</p><p>Financial capital was one key factor impacting on adherence to ARVs and the only type of capital which demonstrated a significant association with adherence. The inability to afford medication was one of the most frequently reported reasons for non-adherence both in included studies <xref ref-type="bibr" rid="pone.0018948-Boyer1">[27]</xref>, <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref>, <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref> as well as in others <xref ref-type="bibr" rid="pone.0018948-Daniel1">[56]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Kumaraswamy1">[58]</xref>. While access to free ARVs was associated with non-adherence in one study <xref ref-type="bibr" rid="pone.0018948-Sarna1">[36]</xref>, individuals receiving free treatment may be more likely to be highly impoverished and facing numerous obstacles (e.g., lack of food, shelter) which impact on their ability to adhere <xref ref-type="bibr" rid="pone.0018948-Moss1">[59]</xref>. Importantly, user fees and charges for treatment are widespread in resource-poor settings <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref> although it has been suggested that optimal levels of adherence can be achieved with access to subsidized ARVs <xref ref-type="bibr" rid="pone.0018948-Weiser1">[41]</xref>, <xref ref-type="bibr" rid="pone.0018948-Orrell1">[45]</xref>. A 2005 meta-analysis focused on ARV programmes in resource-poor settings reported that, in fact, when medications were provided free-of-charge, there was a higher probability of achieving adherence and undetectable viral loads compared to situations where patients were required to pay for treatment <xref ref-type="bibr" rid="pone.0018948-Ivers1">[18]</xref>.</p><p>Even in the context of free drugs however, the cost of transportation to obtain ARVs can still remain a barrier to adherence. Research from sub-Saharan Africa has demonstrated that patients often have to choose between using their limited income on paying for transportation to the clinic versus being able to adequately feed their families <xref ref-type="bibr" rid="pone.0018948-Tuller1">[60]</xref>. As a result, individuals may miss their scheduled clinic appointments and thus not receive their ARVs at the regular time intervals critical for optimal adherence <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Anema1">[61]</xref>. Therefore, increasing access to affordable transportation as well as expanding the number and location of ARV clinics may help to facilitate HIV treatment adherence <xref ref-type="bibr" rid="pone.0018948-Stout1">[38]</xref>, <xref ref-type="bibr" rid="pone.0018948-Cauldbeck1">[62]</xref>.</p><p>Findings related to food-related restrictions i.e. inability to take medications on an empty stomach, and greater adherence when eating well, were also associated with adherence in two studies. Food insecurity has been well-documented in Africa and has been linked with decreased adherence to ARVs and poor clinical outcomes <xref ref-type="bibr" rid="pone.0018948-Anema1">[61]</xref>, <xref ref-type="bibr" rid="pone.0018948-Au1">[63]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Weiser3">[65]</xref>. Medication-related food restrictions place an additional burden on patients, in many ways, increasing the complexity of the treatment regimen itself <xref ref-type="bibr" rid="pone.0018948-Cauldbeck1">[62]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ickovics1">[66]</xref>. The perception that ARVs need to be taken with food may lead to non-adherence <xref ref-type="bibr" rid="pone.0018948-Wang1">[40]</xref>, <xref ref-type="bibr" rid="pone.0018948-Williams1">[42]</xref>, <xref ref-type="bibr" rid="pone.0018948-Sanjobo1">[67]</xref>, <xref ref-type="bibr" rid="pone.0018948-Unge1">[68]</xref> suggesting that access to adequate food via self-production or, at the very least, food supplements, bolsters human capital, recognizing that taking pills on an empty stomach may lead to gastrointestinal upset.</p><p>Social stability and social capital have both been associated with medication adherence in various settings <xref ref-type="bibr" rid="pone.0018948-Remien1">[69]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Nam1">[73]</xref>. Importantly, social support can take the form of direct reminders, financial help, and emotional backing <xref ref-type="bibr" rid="pone.0018948-Watt1">[71]</xref>. Qualitative research from South Africa suggests that treatment supporters (i.e., clinic buddies) are a valuable aid in promoting adherence <xref ref-type="bibr" rid="pone.0018948-Birbeck1">[74]</xref>. As identified in this review, social factors such marital status and having children can impact on adherence. The desire to be alive and be able to support their families and see their children grow up may be a strong motivator for patients to adhere <xref ref-type="bibr" rid="pone.0018948-Uzochukwu1">[39]</xref>, <xref ref-type="bibr" rid="pone.0018948-Remien1">[69]</xref>, <xref ref-type="bibr" rid="pone.0018948-Watt1">[71]</xref>, <xref ref-type="bibr" rid="pone.0018948-World2">[75]</xref>. However, disclosure to one's sexual partner has been recognized as a double edged sword <xref ref-type="bibr" rid="pone.0018948-Birbeck1">[74]</xref>- it has the potential to yield much needed social support <xref ref-type="bibr" rid="pone.0018948-Ramadhani1">[35]</xref> but may also result in stigmatization, discrimination, and potentially abandonment <xref ref-type="bibr" rid="pone.0018948-Birbeck1">[74]</xref>, <xref ref-type="bibr" rid="pone.0018948-Kalichman1">[76]</xref>, <xref ref-type="bibr" rid="pone.0018948-Norman1">[77]</xref>. This may partly explain why adherence was higher for single individuals in one study <xref ref-type="bibr" rid="pone.0018948-ByakikaTusiime1">[28]</xref>. Issues of stigma and discrimination related to HIV/AIDS remain a real concern in many settings <xref ref-type="bibr" rid="pone.0018948-Ncama1">[78]</xref> and may lead to social isolation, limit sources of social capital, and undermine relationships that are essential for survival <xref ref-type="bibr" rid="pone.0018948-Ware1">[70]</xref>, <xref ref-type="bibr" rid="pone.0018948-Ncama1">[78]</xref>. Further research in this area is still needed to help elucidate the type and nature of social capital that impacts on adherence across settings.</p><sec id="s4a"><title>Limitations</title><p>Limitations in our review reflect the quality and nature of included studies. While our search was extensive and we did seek clarification from various study authors, it is possible we missed unpublished studies measuring the association between relevant livelihood factors and adherence. There is no gold standard for measuring adherence -patient recall and pill count, both commonly used, have inherent biases in their use <xref ref-type="bibr" rid="pone.0018948-Berg1">[79]</xref>&#x02013;<xref ref-type="bibr" rid="pone.0018948-Nachega2">[81]</xref>. For example, there is a tendency for self-reported adherence to be positively skewed (i.e., patients overestimating adherence levels) increasing the risk of patient misclassification <xref ref-type="bibr" rid="pone.0018948-Berg1">[79]</xref>. While reporting bias, specifically social desirability bias, may have a profound impact here, other influences may include question misinterpretation and issues of recall <xref ref-type="bibr" rid="pone.0018948-Wagner1">[82]</xref>. Additionally, the lack of methodological standards makes assessments and comparisons between levels of adherence difficult. As such there remains the need for validation of adherence monitoring tools capable of measuring real-time behaviour of patients in various settings <xref ref-type="bibr" rid="pone.0018948-Nachega2">[81]</xref>. While numerous livelihood factors were examined, few were measured using standardized or validated instruments for particular constructs, again reflecting the dearth of research conducted in this area to-date and perhaps the lack of experience among clinical investigators with use of standard measures more out of social science traditions.</p><p>Unmeasured or unidentified features of included studies may also have a large impact on either apparent or real adherence <xref ref-type="bibr" rid="pone.0018948-Mills2">[15]</xref>. Detailed population descriptions (e.g., education level) and the regional and political conditions under which a study was conducted would assist interpretation of future studies in this field. For example, patients with access to private or non-governmental health services may have additional benefits including better access to laboratory equipment and testing <xref ref-type="bibr" rid="pone.0018948-Bonolo1">[43]</xref> which may ultimately affect treatment outcomes. Furthermore, patients in care and on ARVs may differ meaningfully from patients who either lack access to ARVs or who refused treatment. The experiences of livelihood insecurity for these individuals may, in part, explain why they are not or did not remain in care, but such populations were rarely included. Finally, the majority of included studies were cross-sectional in study design, limiting the ability to establish temporal causality (i.e., livelihood to adherence) validly.</p></sec><sec id="s4b"><title>Conclusions</title><p>We found only one significant association that was consistent across settings. We demonstrated a positive association between financial capital and adherence whereas no statistically significant relationship was found for human or social capital and adherence. Importantly, the included studies reflect a range of experiences in the association between various livelihood factors and adherence to ARVs. This heterogeneity and diversity can also be considered an important strength of this review. More longitudinal studies that can effectively measure and monitor the dynamic interactions between livelihood security and adherence across settings are needed. Linked to these could be additional qualitative work able to explore the lives and treatment challenges of PLWHA <xref ref-type="bibr" rid="pone.0018948-Castro1">[83]</xref>. Both study designs are essential for understanding adherence, the way adherence changes over time, and the reasons for non-adherence. Through their incorporation in structural policies or programs, findings from such research can contribute to improved patient outcomes <xref ref-type="bibr" rid="pone.0018948-Naik1">[84]</xref>. Furthermore, clinicians and other health providers can actively work with their patients and help them to prioritize adherence while addressing potential obstacles to care <xref ref-type="bibr" rid="pone.0018948-Naik1">[84]</xref>, <xref ref-type="bibr" rid="pone.0018948-Mondloch1">[85]</xref>. As many of these obstacles and challenges lie beyond the control of the individual patient, addressing adherence in low- and middle-income settings, therefore, may require eliminating or lowering user fees and patient costs, bringing care closer to the patients, and implementing community-based livelihood development strategies.</p></sec></sec></body><back><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>The authors have no support or funding to report.</p></fn></fn-group><ref-list><title>References</title><ref id="pone.0018948-Drimie1"><label>1</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Drimie</surname><given-names>S</given-names></name><name><surname>Mullins</surname><given-names>D</given-names></name></person-group>             <year>2006</year>             <article-title>Mainstreaming HIV and AIDS into livelihood and food security programs: The experience of CARE Malawi.</article-title>             <person-group person-group-type="editor"><name><surname>Gillespie</surname></name><name><surname>S</surname></name></person-group>             <fpage>283</fpage>             <lpage>303</lpage>             <comment>AIDS, poverty, and hunger: Challenges and responses. Highlights of the International Conference on HIV/AIDS and Food and Nutrition Security, Durban South Africa, April 14&#x02013;16, 2005. Washington, DC: International Food Policy Research Network</comment>          </element-citation></ref><ref id="pone.0018948-Elasha1"><label>2</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Elasha</surname><given-names>BO</given-names></name><name><surname>Elhassan</surname><given-names>NG</given-names></name><name><surname>Ahmed</surname><given-names>H</given-names></name><name><surname>Zakeildin</surname><given-names>S</given-names></name></person-group>             <year>2005</year>             <article-title>Sustainable livelihood approach for assessing community resilience to climate change: case studies from Sudan.</article-title>             <comment>Assessments of Impacts and Adaptation to Climate Change working paper No 17. August 2005. Available: <ext-link ext-link-type="uri" xlink:href="http://www.aiaccproject.org/working_papers/Working%20Papers/AIACC_WP_No">http://www.aiaccproject.org/working_papers/Working%20Papers/AIACC_WP_No</ext-link> 017.pdf. Accessed on 3 February, 2010</comment>          </element-citation></ref><ref id="pone.0018948-Carney1"><label>3</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Carney</surname><given-names>B</given-names></name></person-group>             <year>1998</year>             <article-title>Sustainable Rural Livelihoods-what contributions can we make?</article-title>             <comment>Paper presented at the Department of International Development's Natural Resources Advisers' Conference London</comment>          </element-citation></ref><ref id="pone.0018948-DeWaal1"><label>4</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>De Waal</surname><given-names>A</given-names></name><name><surname>Whiteside</surname><given-names>A</given-names></name></person-group>             <year>2003</year>             <article-title>New variant famine: AIDS and food crisis in Southern Africa.</article-title>             <source>Lancet</source>             <volume>362</volume>             <fpage>1234</fpage>             <lpage>1237</lpage>          <pub-id pub-id-type="pmid">14568749</pub-id></element-citation></ref><ref id="pone.0018948-Masanjala1"><label>5</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Masanjala</surname><given-names>W</given-names></name></person-group>             <year>2007</year>             <article-title>The poverty-HIV/AIDS nexus in Africa: a livelihood approach.</article-title>             <source>Soc Sci Med</source>             <volume>64</volume>             <fpage>1032</fpage>             <lpage>1041</lpage>          <pub-id pub-id-type="pmid">17126972</pub-id></element-citation></ref><ref id="pone.0018948-Seeley1"><label>6</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Seeley</surname><given-names>J</given-names></name></person-group>             <year>2002</year>             <article-title>Thinking with the livelihood framework in the context of the HIV/AIDS epidemic.</article-title>             <comment>Research paper, Livelihoods Connect, Institute of Development Studies, University of Sussex</comment>          </element-citation></ref><ref id="pone.0018948-Ellis1"><label>7</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Ellis</surname><given-names>F</given-names></name><name><surname>Kutengule</surname><given-names>M</given-names></name><name><surname>Nyasulu</surname><given-names>A</given-names></name></person-group>             <year>2003</year>             <article-title>Livelihoods and rural poverty education in Malawi.</article-title>             <source>World Dev</source>             <volume>31</volume>             <fpage>1495</fpage>             <lpage>1510</lpage>          </element-citation></ref><ref id="pone.0018948-Hogg1"><label>8</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Hogg</surname><given-names>RS</given-names></name><name><surname>O'Shaughnessy</surname><given-names>MV</given-names></name><name><surname>Gataric</surname><given-names>N</given-names></name><name><surname>Yip</surname><given-names>B</given-names></name><name><surname>Craib</surname><given-names>K</given-names></name><etal/></person-group>             <year>1997</year>             <article-title>Decline in deaths from AIDS due to new antiretrovirals.</article-title>             <source>Lancet</source>             <volume>349</volume>             <fpage>1294</fpage>          <pub-id pub-id-type="pmid">9142067</pub-id></element-citation></ref><ref id="pone.0018948-Mannheimer1"><label>9</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Mannheimer</surname><given-names>SB</given-names></name><name><surname>Matts</surname><given-names>J</given-names></name><name><surname>Telzak</surname><given-names>E</given-names></name><name><surname>Chesney</surname><given-names>M</given-names></name><name><surname>Child</surname><given-names>C</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence.</article-title>             <source>AIDS Care,</source>             <volume>1</volume>             <fpage>10</fpage>             <lpage>22</lpage>          <pub-id pub-id-type="pmid">15832830</pub-id></element-citation></ref><ref id="pone.0018948-Joint1"><label>10</label><element-citation publication-type="other">             <collab>Joint United Nations Programme on HIV/AIDS</collab>             <year>2009</year>             <comment>Report on the Global AIDS Pandemic. Available: <ext-link ext-link-type="uri" xlink:href="http://www.unaids.org/en/KnowledgeCentre/HIVData/Global-Report/2009/">http://www.unaids.org/en/KnowledgeCentre/HIVData/Global-Report/2009/</ext-link>. Accessed on 3 Jan 2010</comment>          </element-citation></ref><ref id="pone.0018948-Gavian1"><label>11</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Gavian</surname><given-names>S</given-names></name><name><surname>Galaty</surname><given-names>D</given-names></name><name><surname>Kombe</surname></name><name><surname>K</surname></name></person-group>             <year>2006</year>             <article-title>Multisectoral HIV/AIDS approaches in Africa: How are they evolving?</article-title>             <person-group person-group-type="editor"><name><surname>Gillespie</surname></name><name><surname>S</surname></name></person-group>             <fpage>221</fpage>             <lpage>243</lpage>             <comment>AIDS, poverty, and hunger Challenges and responses. Highlights of the International Conference on HIV/AIDS and Food and Nutrition Security, Durban South Africa, April 14&#x02013;16, 2005. Washington, DC: International Food Policy Research Network</comment>          </element-citation></ref><ref id="pone.0018948-Bangsberg1"><label>12</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Bangsberg</surname><given-names>DR</given-names></name><name><surname>Perry</surname><given-names>S</given-names></name><name><surname>Charlesbois</surname><given-names>ED</given-names></name><name><surname>Clark</surname><given-names>RA</given-names></name><name><surname>Robertson</surname><given-names>M</given-names></name><etal/></person-group>             <year>2001</year>             <article-title>Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.</article-title>             <source>AIDS</source>             <volume>15</volume>             <fpage>1181</fpage>             <lpage>1183</lpage>          <pub-id pub-id-type="pmid">11416722</pub-id></element-citation></ref><ref id="pone.0018948-Wood1"><label>13</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Wood</surname><given-names>E</given-names></name><name><surname>Hogg</surname><given-names>RS</given-names></name><name><surname>Yip</surname><given-names>B</given-names></name><name><surname>Harrigan</surname><given-names>PR</given-names></name><name><surname>O'Shaughnessy</surname><given-names>MV</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Is there a baseline CD4 count that precludes a survival response to modern antiretroviral therapy?</article-title>             <source>AIDS</source>             <volume>17</volume>             <fpage>711</fpage>             <lpage>720</lpage>          <pub-id pub-id-type="pmid">12646794</pub-id></element-citation></ref><ref id="pone.0018948-Mills1"><label>14</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Mills</surname><given-names>EJ</given-names></name><name><surname>Nachega</surname><given-names>JB</given-names></name><name><surname>Buchan</surname><given-names>I</given-names></name><name><surname>Orbinski</surname><given-names>J</given-names></name><name><surname>Attaran</surname><given-names>A</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Adherence to antiretroviral therapy in sub-Saharan Africa and North America. A meta-analysis.</article-title>             <source>JAMA</source>             <volume>296</volume>             <fpage>679</fpage>             <lpage>690</lpage>          <pub-id pub-id-type="pmid">16896111</pub-id></element-citation></ref><ref id="pone.0018948-Mills2"><label>15</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Mills</surname><given-names>EJ</given-names></name><name><surname>Nachega</surname><given-names>JB</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Rachlis</surname><given-names>B</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.</article-title>             <source>PLoS Med</source>             <volume>3</volume>             <fpage>e438</fpage>          <pub-id pub-id-type="pmid">17121449</pub-id></element-citation></ref><ref id="pone.0018948-Altice1"><label>16</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Altice</surname><given-names>FL</given-names></name><name><surname>Mostashari</surname><given-names>F</given-names></name><name><surname>Friedland</surname><given-names>GH</given-names></name></person-group>             <year>2001</year>             <article-title>Trust and the acceptance of and adherence to antiretroviral therapy.</article-title>             <source>JAIDS</source>             <volume>1</volume>             <fpage>47</fpage>             <lpage>58</lpage>          <pub-id pub-id-type="pmid">11579277</pub-id></element-citation></ref><ref id="pone.0018948-Loevinsohn1"><label>17</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Loevinsohn</surname><given-names>M</given-names></name><name><surname>Gillespie</surname><given-names>SR</given-names></name></person-group>             <year>2003</year>             <article-title>HIV/AIDS, rural livelihoods and food security: understanding and responding.</article-title>             <comment>RENEWAL Working paper No 2. Available: <ext-link ext-link-type="uri" xlink:href="http://www.isnar.org/renewal">www.isnar.org/renewal</ext-link>. Accessed on 10 Jan 2010</comment>          </element-citation></ref><ref id="pone.0018948-Ivers1"><label>18</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Ivers</surname><given-names>L</given-names></name><name><surname>Kendrick</surname><given-names>D</given-names></name><name><surname>Doucette</surname><given-names>K</given-names></name></person-group>             <year>2005</year>             <article-title>Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analyses of the published literature.</article-title>             <source>HIV/AIDS Clin Infect Dis</source>             <volume>41</volume>             <fpage>217</fpage>             <lpage>24</lpage>          </element-citation></ref><ref id="pone.0018948-UK1"><label>19</label><element-citation publication-type="other">             <collab>UK Department of Development</collab>             <year>2004</year>             <article-title>Sustainable livelihoods guidance sheets.</article-title>             <comment>London, Department for International Development. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ennonline.net/pool/files/ife/section2.pdf">http://www.ennonline.net/pool/files/ife/section2.pdf</ext-link>. Accessed on 20 July 2009</comment>          </element-citation></ref><ref id="pone.0018948-Stroup1"><label>20</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Stroup</surname><given-names>DF</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><name><surname>Morton</surname><given-names>CS</given-names></name><name><surname>Olkin</surname><given-names>I</given-names></name><name><surname>Williamson</surname><given-names>GD</given-names></name><etal/></person-group>             <year>2000</year>             <article-title>Meta-analysis of observational studies in epidemiology. A proposal for reporting.</article-title>             <source>JAMA</source>             <volume>282</volume>             <fpage>2008</fpage>             <lpage>2012</lpage>          <pub-id pub-id-type="pmid">10789670</pub-id></element-citation></ref><ref id="pone.0018948-World1"><label>21</label><element-citation publication-type="other">             <comment>World Bank. Country Classification Table. Available: <ext-link ext-link-type="uri" xlink:href="http://go.worldbank.org/K2CKM78CC0">http://go.worldbank.org/K2CKM78CC0</ext-link>. Accessed on 10 Jan 2010</comment>          </element-citation></ref><ref id="pone.0018948-Katrak1"><label>22</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Katrak</surname><given-names>P</given-names></name><name><surname>Bialocerkowski</surname><given-names>AE</given-names></name><name><surname>Massy-Westropp</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>VSS</given-names></name><name><surname>Grimmer</surname><given-names>KA</given-names></name></person-group>             <year>2004</year>             <article-title>A systematic review of the content of critical appraisal tools.</article-title>             <source>BMC Med Res Method</source>             <volume>4</volume>             <fpage>22</fpage>          </element-citation></ref><ref id="pone.0018948-VonElm1"><label>23</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Von Elm</surname><given-names>E</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Gotzsche</surname><given-names>PC</given-names></name><etal/></person-group>             <collab>STROBE Initiative</collab>             <year>2008</year>             <article-title>The strengthening of reporting of observational studies in epidemiology (STROBE) statement guidelines for reporting observational studies.</article-title>             <source>J Clin Epidemiol</source>             <volume>61</volume>             <fpage>344</fpage>             <lpage>9</lpage>          <pub-id pub-id-type="pmid">18313558</pub-id></element-citation></ref><ref id="pone.0018948-Vandenbroucke1"><label>24</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Vandenbroucke</surname><given-names>JP</given-names></name><name><surname>von Elm</surname><given-names>E</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Gotzsche</surname><given-names>PC</given-names></name><name><surname>Mulrow</surname><given-names>CD</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration.</article-title>             <source>PLoS Med</source>             <volume>4</volume>             <fpage>e297</fpage>          <pub-id pub-id-type="pmid">17941715</pub-id></element-citation></ref><ref id="pone.0018948-Public1"><label>25</label><element-citation publication-type="other">             <comment>Public Health Resource Unit. Critical appraisal skills programme: making sense of evidence. 12 Questions to help you make sense of a cohort study. Available: <ext-link ext-link-type="uri" xlink:href="http://www.phru.nhs.uk/Doc_Links/cohort%2012%20questions.pdf">http://www.phru.nhs.uk/Doc_Links/cohort%2012%20questions.pdf</ext-link>. Accessed on 31 January 2010</comment>          </element-citation></ref><ref id="pone.0018948-Aboubacrine1"><label>26</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Aboubacrine</surname><given-names>SA</given-names></name><name><surname>Niamba</surname><given-names>P</given-names></name><name><surname>Bioleau</surname><given-names>C</given-names></name><name><surname>Zunzunegui</surname><given-names>MV</given-names></name><name><surname>Machouf</surname><given-names>N</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Inadequate adherence to antiretroviral treatment and prevention in hospital and community sites in Burkina Faso and Mali: a study by the ATARAO group.</article-title>             <source>Int J STD AIDS</source>             <volume>18</volume>             <fpage>741</fpage>             <lpage>7</lpage>          <pub-id pub-id-type="pmid">18005507</pub-id></element-citation></ref><ref id="pone.0018948-Boyer1"><label>27</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Boyer</surname><given-names>S</given-names></name><name><surname>Marcellin</surname><given-names>F</given-names></name><name><surname>Ongolo-Zogo</surname><given-names>P</given-names></name><name><surname>Abega</surname><given-names>SC</given-names></name><name><surname>Nantchouang</surname><given-names>R</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Financial barriers to HIV treatment in Yaound&#x000e9;, Cameroon: first results of a national cross-sectional survey.</article-title>             <source>Bull World Health Organ</source>             <volume>87</volume>             <fpage>279</fpage>             <lpage>87</lpage>          <pub-id pub-id-type="pmid">19551236</pub-id></element-citation></ref><ref id="pone.0018948-ByakikaTusiime1"><label>28</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Byakika-Tusiime</surname><given-names>J</given-names></name><name><surname>Oyugi</surname><given-names>JH</given-names></name><name><surname>Tumwikirize</surname><given-names>WA</given-names></name><name><surname>Katabira</surname><given-names>ET</given-names></name><name><surname>Mugyenyi</surname><given-names>PN</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Adherence to HIV antiretroviral therapy in HIV&#x0002b;Ugandan patients purchasing therapy.</article-title>             <source>Int J STD AIDS</source>             <volume>16</volume>             <fpage>38</fpage>             <lpage>41</lpage>          <pub-id pub-id-type="pmid">15705271</pub-id></element-citation></ref><ref id="pone.0018948-Carlucci1"><label>29</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Carlucci</surname><given-names>JG</given-names></name><name><surname>Kamanga</surname><given-names>A</given-names></name><name><surname>Sheneberger</surname><given-names>R</given-names></name><name><surname>Shepherd</surname><given-names>BE</given-names></name><name><surname>Jenkins</surname><given-names>CA</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Predictors of adherence to antiretroviral therapy in rural Zambia.</article-title>             <source>JAIDS</source>             <volume>47</volume>             <fpage>615</fpage>             <lpage>622</lpage>          <pub-id pub-id-type="pmid">18209678</pub-id></element-citation></ref><ref id="pone.0018948-Iliyasu1"><label>30</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Iliyasu</surname><given-names>Z</given-names></name><name><surname>Kabir</surname><given-names>M</given-names></name><name><surname>Abubakar</surname><given-names>IS</given-names></name><name><surname>Babashani</surname><given-names>M</given-names></name><name><surname>Zubair</surname><given-names>ZA</given-names></name></person-group>             <year>2005</year>             <article-title>Compliance to antiretroviral therapy among AIDS patients in Amino Kano Teaching Hospital, Kano, Nigeria.</article-title>             <source>Niger J Med</source>             <volume>14</volume>             <fpage>290</fpage>             <lpage>4</lpage>          <pub-id pub-id-type="pmid">16350700</pub-id></element-citation></ref><ref id="pone.0018948-Malangu1"><label>31</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Malangu</surname><given-names>NG</given-names></name></person-group>             <year>2008</year>             <article-title>Self-reported adverse effects as barriers to adherence to antiretroviral therapy in HIV-infected patients in Pretoria.</article-title>             <source>SA Family Practice</source>             <volume>50</volume>             <fpage>49</fpage>          </element-citation></ref><ref id="pone.0018948-Nachega1"><label>32</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Nachega</surname><given-names>JB</given-names></name><name><surname>Stein</surname><given-names>DM</given-names></name><name><surname>Lehman</surname><given-names>DA</given-names></name><name><surname>Hlatshwayo</surname><given-names>D</given-names></name><name><surname>Mothopeng</surname><given-names>R</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa.</article-title>             <source>AIDS Res Human Retro</source>             <volume>20</volume>             <fpage>1053</fpage>             <lpage>1056</lpage>          </element-citation></ref><ref id="pone.0018948-Nemes1"><label>33</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Nemes</surname><given-names>MI</given-names></name><name><surname>Carvalho</surname><given-names>HB</given-names></name><name><surname>Souza</surname><given-names>MF</given-names></name></person-group>             <year>2004</year>             <article-title>Antiretroviral therapy adherence in Brazil.</article-title>             <source>AIDS 18</source>             <issue>Suppl 3</issue>             <fpage>S15</fpage>             <lpage>20</lpage>          </element-citation></ref><ref id="pone.0018948-Pinheiro1"><label>34</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>CAT</given-names></name><name><surname>de-Carvalho-Leite</surname><given-names>JC</given-names></name><name><surname>Drachler</surname><given-names>ML</given-names></name><name><surname>Silveria</surname><given-names>VL</given-names></name></person-group>             <year>2002</year>             <article-title>Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil.</article-title>             <source>Br J Med Biological Research</source>             <volume>35</volume>             <fpage>1173</fpage>             <lpage>1181</lpage>          </element-citation></ref><ref id="pone.0018948-Ramadhani1"><label>35</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Ramadhani</surname><given-names>HO</given-names></name><name><surname>Thielman</surname><given-names>NM</given-names></name><name><surname>Landman</surname><given-names>KZ</given-names></name><name><surname>Ndosi</surname><given-names>EM</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.</article-title>             <source>Clin Infect Dis</source>             <volume>45</volume>             <fpage>1492</fpage>             <lpage>8</lpage>          <pub-id pub-id-type="pmid">17990233</pub-id></element-citation></ref><ref id="pone.0018948-Sarna1"><label>36</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Sarna</surname><given-names>A</given-names></name><name><surname>Pujari</surname><given-names>S</given-names></name><name><surname>Sengar</surname><given-names>AK</given-names></name><name><surname>Garg</surname><given-names>R</given-names></name><name><surname>Gupta</surname><given-names>I</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Adherence to antiretroviral therapy &#x00026; its determinants amongst HIV patients in India.</article-title>             <source>Ind J Med Res</source>             <volume>127</volume>             <fpage>28</fpage>             <lpage>36</lpage>          </element-citation></ref><ref id="pone.0018948-Silva1"><label>37</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Silva</surname><given-names>MCF</given-names></name><name><surname>Ximenes</surname><given-names>RAA</given-names></name><name><surname>Mirando Filho</surname><given-names>DB</given-names></name><name><surname>Arraes</surname><given-names>LWMS</given-names></name><name><surname>Mendes</surname><given-names>M</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Risk factors for non-adherence to antiretroviral therapy.</article-title>             <source>Rev Inst Med Trop S. Paulo</source>             <volume>51</volume>             <fpage>135</fpage>             <lpage>139</lpage>          <pub-id pub-id-type="pmid">19551287</pub-id></element-citation></ref><ref id="pone.0018948-Stout1"><label>38</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Stout</surname><given-names>BD</given-names></name><name><surname>Leon</surname><given-names>MP</given-names></name><name><surname>Niccolai</surname><given-names>LM</given-names></name></person-group>             <year>2004</year>             <article-title>Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica.</article-title>             <source>AIDS Patient Care STDS</source>             <volume>18</volume>             <fpage>297</fpage>             <lpage>304</lpage>          <pub-id pub-id-type="pmid">15186713</pub-id></element-citation></ref><ref id="pone.0018948-Uzochukwu1"><label>39</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Uzochukwu</surname><given-names>BSC</given-names></name><name><surname>Onwujekwe</surname><given-names>OE</given-names></name><name><surname>ONoka</surname><given-names>AC</given-names></name><name><surname>Okoli</surname><given-names>C</given-names></name><name><surname>Uguru</surname><given-names>NP</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria.</article-title>             <source>Health Policy Plan</source>             <volume>24</volume>             <fpage>189</fpage>             <lpage>96</lpage>          <pub-id pub-id-type="pmid">19276155</pub-id></element-citation></ref><ref id="pone.0018948-Wang1"><label>40</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name></person-group>             <year>2007</year>             <article-title>Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China.</article-title>             <source>AIDS 21</source>                    <issue>Suppl 8</issue>             <fpage>S149</fpage>             <lpage>S155</lpage>          </element-citation></ref><ref id="pone.0018948-Weiser1"><label>41</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Weiser</surname><given-names>S</given-names></name><name><surname>Wolfe</surname><given-names>W</given-names></name><name><surname>Bangsberg</surname><given-names>D</given-names></name><name><surname>Thior</surname><given-names>I</given-names></name><name><surname>Gilbert</surname><given-names>P</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana.</article-title>             <source>JAIDS</source>             <volume>34</volume>             <fpage>281</fpage>             <lpage>288</lpage>          <pub-id pub-id-type="pmid">14600572</pub-id></element-citation></ref><ref id="pone.0018948-Williams1"><label>42</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Williams</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>T</given-names></name><name><surname>Williams</surname><given-names>P</given-names></name><name><surname>Barton</surname><given-names>EN</given-names></name></person-group>             <year>2007</year>             <article-title>The mean levels of adherence and factors contributing to non-adherence in patients on highly active antiretroviral therapy.</article-title>             <source>West Indian Med J</source>             <volume>56</volume>             <fpage>270</fpage>          <pub-id pub-id-type="pmid">18072411</pub-id></element-citation></ref><ref id="pone.0018948-Bonolo1"><label>43</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Bonolo</surname><given-names>P</given-names></name><name><surname>Cesar</surname><given-names>CC</given-names></name><name><surname>Acurcio</surname><given-names>FA</given-names></name><name><surname>Ceccato</surname><given-names>MGB</given-names></name><name><surname>de Padua</surname><given-names>CM</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil.</article-title>             <source>AIDS</source>             <volume>19</volume>             <fpage>S5</fpage>             <lpage>13</lpage>          <pub-id pub-id-type="pmid">16249654</pub-id></element-citation></ref><ref id="pone.0018948-Erah1"><label>44</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Erah</surname><given-names>PO</given-names></name><name><surname>Arute</surname><given-names>JE</given-names></name></person-group>             <year>2008</year>             <article-title>Adherence of HIV/AIDS patients to antiretroviral therapy in a tertiary health facility in Benin City.</article-title>             <source>Afr J Pharmacy Pharmacology</source>             <volume>2</volume>             <fpage>145</fpage>             <lpage>152</lpage>          </element-citation></ref><ref id="pone.0018948-Orrell1"><label>45</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Orrell</surname><given-names>C</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name><name><surname>Badri</surname><given-names>M</given-names></name><name><surname>Wood</surname><given-names>R</given-names></name></person-group>             <year>2003</year>             <article-title>Adherence is not a barrier to successful antiretroviral therapy in South Africa.</article-title>             <source>AIDS</source>             <volume>17</volume>             <fpage>1369</fpage>             <lpage>75</lpage>          <pub-id pub-id-type="pmid">12799558</pub-id></element-citation></ref><ref id="pone.0018948-Dahab1"><label>46</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Dahab</surname><given-names>M</given-names></name><name><surname>Charalambous</surname><given-names>S</given-names></name><name><surname>Hamilton</surname><given-names>R</given-names></name><name><surname>Fielding</surname><given-names>K</given-names></name><name><surname>Tsimele</surname><given-names>J</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>A quantitative study of barriers &#x00026; facilitators to adherence in an ART programme in South Africa.</article-title>             <comment>AIDS 2006-XVI International AIDS Conference: Abstract no. TUPE0151</comment>          </element-citation></ref><ref id="pone.0018948-Shah1"><label>47</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Shah</surname><given-names>B</given-names></name><name><surname>Walshe</surname><given-names>L</given-names></name><name><surname>Saple</surname><given-names>DG</given-names></name><name><surname>Mehta</surname><given-names>S</given-names></name><name><surname>Kharkar</surname><given-names>JP</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Adherence to antiretroviral therapy among Indian HIV-infected persons seeking care in the private sector in Mumbai, India.</article-title>             <comment>AIDS 2006-XVI International AIDS Conference: Abstract no. THPE0194</comment>          </element-citation></ref><ref id="pone.0018948-Warley1"><label>48</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Warley</surname><given-names>E</given-names></name><name><surname>Shield</surname><given-names>D</given-names></name><name><surname>Salas</surname><given-names>M</given-names></name><name><surname>Vienie</surname><given-names>I</given-names></name><name><surname>Moneti</surname><given-names>S</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Adherence to antiretroviral therapy in a population of the low-income suburbs of Buenos Aires, Argentina.</article-title>             <comment>AIDS 2006-XVI International AIDS Conference: Abstract no. CDB0805</comment>          </element-citation></ref><ref id="pone.0018948-Abah1"><label>49</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Abah</surname><given-names>IO</given-names></name><name><surname>Falang</surname><given-names>K</given-names></name><name><surname>Finangwi</surname><given-names>A</given-names></name><name><surname>Iyaji</surname><given-names>P</given-names></name><name><surname>Wakdet</surname><given-names>L</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Adherence to antiretroviral therapy in HIV-infected adults in Jos, Nigeria.</article-title>             <comment>AIDS 2006-XVI International AIDS Conference: Abstract no. TUPE0105</comment>          </element-citation></ref><ref id="pone.0018948-Darder1"><label>50</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Darder</surname><given-names>M</given-names></name><name><surname>Michaels</surname><given-names>D</given-names></name><name><surname>Boulle</surname><given-names>A</given-names></name><name><surname>Ncobo</surname><given-names>N</given-names></name><name><surname>MacLean</surname><given-names>E</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Determinants of short and long-term adherence to antiretroviral treatment in resource-poor settings.</article-title>             <comment>CD Only: The XV International AIDS Conference 2004: Abstract no. B11852</comment>          </element-citation></ref><ref id="pone.0018948-Sidle1"><label>51</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Sidle</surname><given-names>J</given-names></name><name><surname>Kimaiyo</surname><given-names>S</given-names></name><name><surname>Monahan</surname><given-names>P</given-names></name><name><surname>Nyandiko</surname><given-names>W</given-names></name><name><surname>Wools-Kaloustian</surname><given-names>K</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Patterns of antiretroviral adherence among Kenyan patients and factors related to non-adherence during the first year of treatment.</article-title>             <comment>Poster exhibition: 4<sup>th</sup> IAS Conference no HIV Pathogenesis, Treatment, and Prevention 2007: Abstract no. WEPEB099</comment>          </element-citation></ref><ref id="pone.0018948-Shelton1"><label>52</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Shelton</surname><given-names>JD</given-names></name></person-group>             <year>2007</year>             <article-title>Ten myths and one truth about generalised HIV epidemics.</article-title>             <source>Lancet</source>             <volume>370</volume>             <fpage>1809</fpage>             <lpage>11</lpage>          <pub-id pub-id-type="pmid">18061042</pub-id></element-citation></ref><ref id="pone.0018948-Talam1"><label>53</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Talam</surname><given-names>NC</given-names></name><name><surname>Gatongi</surname><given-names>P</given-names></name><name><surname>Rotich</surname><given-names>J</given-names></name><name><surname>Kimaiyo</surname><given-names>S</given-names></name></person-group>             <year>2008</year>             <article-title>Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and referral hospital, Eldoret, Kenya.</article-title>             <source>East Afr J Public Health</source>             <volume>5</volume>             <fpage>74</fpage>             <lpage>78</lpage>          <pub-id pub-id-type="pmid">19024414</pub-id></element-citation></ref><ref id="pone.0018948-Nwauche1"><label>54</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Nwauche</surname><given-names>CA</given-names></name><name><surname>Erhabor</surname><given-names>O</given-names></name><name><surname>Ejele</surname><given-names>OA</given-names></name><name><surname>Akani</surname><given-names>C</given-names></name></person-group>             <year>2006</year>             <article-title>Adherence to antiretroviral therapy among HIV-infected subjects in resource-limited setting in the Niger Delta of Nigeria.</article-title>             <source>Afr J Health Sci</source>             <volume>13</volume>             <fpage>13</fpage>             <lpage>17</lpage>          </element-citation></ref><ref id="pone.0018948-Bandura1"><label>55</label><element-citation publication-type="other">             <person-group person-group-type="author"><name><surname>Bandura</surname><given-names>A</given-names></name></person-group>             <year>1997</year>             <article-title>Self-efficacy: the exercise of control.</article-title>             <comment>W.H. Freeman &#x00026; Company. New York, NY, USA</comment>          </element-citation></ref><ref id="pone.0018948-Daniel1"><label>56</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Daniel</surname><given-names>OJ</given-names></name></person-group>             <year>2004</year>             <article-title>Adherence pattern to ARV drugs among patients on self-purchased drugs and those on free medications in Sagamu, Nigeria. XV International AIDS Conference, Thailand.</article-title>             <source>Abstract</source>             <volume>WePeB5768</volume>          </element-citation></ref><ref id="pone.0018948-Laniece1"><label>57</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Laniece</surname><given-names>I</given-names></name><name><surname>Ciss</surname><given-names>M</given-names></name><name><surname>Desclaux</surname><given-names>A</given-names></name><name><surname>Diop</surname><given-names>K</given-names></name><name><surname>Mbodje</surname><given-names>F</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Adherence to HAART and its principal determinants in a cohort of Senegalese adults.</article-title>             <source>AIDS 17</source>                   <issue>Suppl 3</issue>             <fpage>S103</fpage>             <lpage>108</lpage>          </element-citation></ref><ref id="pone.0018948-Kumaraswamy1"><label>58</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Kumaraswamy</surname><given-names>N</given-names></name><name><surname>Safren</surname><given-names>SA</given-names></name><name><surname>Raminani</surname><given-names>SR</given-names></name><name><surname>Pickard</surname><given-names>R</given-names></name><name><surname>James</surname><given-names>R</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Barriers and facilitators to antiretroviral medication adherence among patients living with HIV in Chennai, India; A qualitative study AIDS Patient Care STDS</article-title>             <volume>19</volume>             <fpage>526</fpage>             <lpage>37</lpage>          </element-citation></ref><ref id="pone.0018948-Moss1"><label>59</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Moss</surname><given-names>AR</given-names></name><name><surname>Hahn</surname><given-names>JA</given-names></name><name><surname>Perry</surname><given-names>S</given-names></name><name><surname>Charlesbois</surname><given-names>ED</given-names></name><name><surname>Guzman</surname><given-names>D</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Adherence to highly active antiretroviral therapy in the homeless population of San Francisco: A prospective study.</article-title>             <source>Clin Infect Dis</source>             <volume>39</volume>             <fpage>1190</fpage>             <lpage>1198</lpage>          <pub-id pub-id-type="pmid">15486844</pub-id></element-citation></ref><ref id="pone.0018948-Tuller1"><label>60</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Tuller</surname><given-names>DM</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name><name><surname>Senkungu</surname><given-names>J</given-names></name><name><surname>Ware</surname><given-names>NC</given-names></name><name><surname>Emenyonu</surname><given-names>N</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Transportation costs impeded sustained adherence and access to HAART in a clinic population in Southwestern Uganda: a qualitative study.</article-title>             <source>AIDS Behav</source>             <volume>14</volume>             <fpage>778</fpage>             <lpage>84</lpage>          <pub-id pub-id-type="pmid">19283464</pub-id></element-citation></ref><ref id="pone.0018948-Anema1"><label>61</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Anema</surname><given-names>A</given-names></name><name><surname>Vogenthaler</surname><given-names>N</given-names></name><name><surname>Frongillo</surname><given-names>EA</given-names></name><name><surname>Kadiyala</surname><given-names>S</given-names></name><name><surname>Weiser</surname><given-names>SD</given-names></name></person-group>             <year>2009</year>             <article-title>Food insecurity and HIV/AIDS: current knowledge, gaps, and research priorities.</article-title>             <source>Curr HIV/AIDS Res</source>             <volume>6</volume>             <fpage>224</fpage>             <lpage>231</lpage>          </element-citation></ref><ref id="pone.0018948-Cauldbeck1"><label>62</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Cauldbeck</surname><given-names>MB</given-names></name><name><surname>O'Connor</surname><given-names>C</given-names></name><name><surname>O'Connor</surname><given-names>MB</given-names></name><name><surname>Saunders</surname><given-names>JA</given-names></name><name><surname>Rao</surname><given-names>B</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Adherence to antiretroviral therapy among HIV patients in Bangalore India.</article-title>             <source>AIDS Res Ther</source>             <volume>6</volume>             <fpage>7</fpage>          <pub-id pub-id-type="pmid">19400929</pub-id></element-citation></ref><ref id="pone.0018948-Au1"><label>63</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Au</surname><given-names>JT</given-names></name><name><surname>Kayitenkore</surname><given-names>K</given-names></name><name><surname>Shutes</surname><given-names>E</given-names></name><name><surname>Karita</surname><given-names>E</given-names></name><name><surname>Peters</surname><given-names>PJ</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda.</article-title>             <source>AIDS</source>             <volume>20</volume>             <fpage>2116</fpage>             <lpage>18</lpage>          <pub-id pub-id-type="pmid">17053359</pub-id></element-citation></ref><ref id="pone.0018948-Weiser2"><label>64</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Weiser</surname><given-names>SD</given-names></name><name><surname>Frongillo</surname><given-names>EA</given-names></name><name><surname>Ragland</surname><given-names>K</given-names></name><name><surname>Hogg</surname><given-names>RS</given-names></name><name><surname>Riley</surname><given-names>ED</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco.</article-title>             <source>J Gen Intern Med</source>             <volume>24</volume>             <fpage>14</fpage>             <lpage>20</lpage>          <pub-id pub-id-type="pmid">18953617</pub-id></element-citation></ref><ref id="pone.0018948-Weiser3"><label>65</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Weiser</surname><given-names>SD</given-names></name><name><surname>Fernandes</surname><given-names>K</given-names></name><name><surname>Brandson</surname><given-names>EK</given-names></name><name><surname>Lima</surname><given-names>VD</given-names></name><name><surname>Anema</surname><given-names>A</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>The association between food insecurity and mortality among HIV-infected individuals on HAART.</article-title>             <source>JAIDS</source>             <volume>52</volume>             <fpage>342</fpage>             <lpage>9</lpage>          <pub-id pub-id-type="pmid">19675463</pub-id></element-citation></ref><ref id="pone.0018948-Ickovics1"><label>66</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Ickovics</surname><given-names>JR</given-names></name><name><surname>Meade</surname><given-names>CS</given-names></name></person-group>             <year>2002</year>             <article-title>Adherence to HAART among patients with HIV: breakthroughs and barriers AIDS Care</article-title>             <volume>14</volume>             <fpage>309</fpage>             <lpage>318</lpage>          </element-citation></ref><ref id="pone.0018948-Sanjobo1"><label>67</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Sanjobo</surname><given-names>N</given-names></name><name><surname>Frich</surname><given-names>JC</given-names></name><name><surname>Freitheim</surname><given-names>A</given-names></name></person-group>             <year>2008</year>             <article-title>Barriers and facilitators to patients' adherence to antiretroviral adherence to antiretroviral treatment in Zambia.</article-title>             <source>SAHARA J</source>             <volume>5</volume>             <fpage>136</fpage>             <lpage>43</lpage>          <pub-id pub-id-type="pmid">18979047</pub-id></element-citation></ref><ref id="pone.0018948-Unge1"><label>68</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Unge</surname><given-names>C</given-names></name><name><surname>Johansson</surname><given-names>A</given-names></name><name><surname>Zachariah</surname><given-names>R</given-names></name><name><surname>Some</surname><given-names>D</given-names></name><name><surname>Van Engelgem</surname><given-names>I</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Reasons for unsatisfactory acceptance of antiretroviral treatment in the urban Kibera slum, Kenya.</article-title>             <source>AIDS Care</source>             <volume>20</volume>             <fpage>146</fpage>             <lpage>49</lpage>          <pub-id pub-id-type="pmid">18293122</pub-id></element-citation></ref><ref id="pone.0018948-Remien1"><label>69</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Remien</surname><given-names>RH</given-names></name><name><surname>Hirky</surname><given-names>AE</given-names></name><name><surname>Johnson</surname><given-names>MO</given-names></name><name><surname>Weinhardt</surname><given-names>LS</given-names></name><name><surname>Whittier</surname><given-names>D</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV&#x0002b; men and women in four US cities AIDS Behav</article-title>             <volume>7</volume>             <fpage>61</fpage>             <lpage>72</lpage>          </element-citation></ref><ref id="pone.0018948-Ware1"><label>70</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Ware</surname><given-names>NC</given-names></name><name><surname>Idoko</surname><given-names>J</given-names></name><name><surname>Kaaya</surname><given-names>S</given-names></name><name><surname>Biararo</surname><given-names>IA</given-names></name><name><surname>Wyatt</surname><given-names>MA</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Explaining adherence successes in sub-Saharan Africa: an ethnographic study.</article-title>             <source>PLoS Med</source>             <volume>6</volume>             <fpage>e1000011</fpage>          </element-citation></ref><ref id="pone.0018948-Watt1"><label>71</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Watt</surname><given-names>MH</given-names></name><name><surname>Maman</surname><given-names>S</given-names></name><name><surname>Earp</surname><given-names>JA</given-names></name><name><surname>Eng</surname><given-names>E</given-names></name><name><surname>Setel</surname><given-names>PW</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>&#x0201c;It's all the time in my mind&#x0201d;: Facilitators of adherence to antiretroviral therapy in a Tanzanian setting.</article-title>             <source>Soc Sci Med</source>             <volume>68</volume>             <fpage>1793</fpage>             <lpage>1800</lpage>          <pub-id pub-id-type="pmid">19328609</pub-id></element-citation></ref><ref id="pone.0018948-Diabete1"><label>72</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Diabete</surname><given-names>S</given-names></name><name><surname>Alary</surname><given-names>M</given-names></name><name><surname>Koffi</surname><given-names>CK</given-names></name></person-group>             <year>2007</year>             <article-title>Determinants of adherence to highly active antiretroviral therapy among HIV-1 infected patients in Cote D'Ivoire.</article-title>             <source>AIDS</source>             <volume>21</volume>             <fpage>1799</fpage>             <lpage>1803</lpage>          <pub-id pub-id-type="pmid">17690579</pub-id></element-citation></ref><ref id="pone.0018948-Nam1"><label>73</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Nam</surname><given-names>SL</given-names></name><name><surname>Fielding</surname><given-names>K</given-names></name><name><surname>Avalos</surname><given-names>A</given-names></name><name><surname>Dickenson</surname><given-names>D</given-names></name><name><surname>Gaoathe</surname><given-names>T</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana.</article-title>             <source>Soc Sci Med</source>             <volume>67</volume>             <fpage>301</fpage>             <lpage>10</lpage>          <pub-id pub-id-type="pmid">18455285</pub-id></element-citation></ref><ref id="pone.0018948-Birbeck1"><label>74</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Birbeck</surname><given-names>GL</given-names></name><name><surname>Chomba</surname><given-names>E</given-names></name><name><surname>Kvalsund</surname><given-names>M</given-names></name><name><surname>Bradbury</surname><given-names>R</given-names></name><name><surname>Mang'ombe</surname><given-names>C</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Antiretroviral adherence in Rural Zambia; the first year of treatment availability.</article-title>             <source>Am J Trop Med</source>             <volume>80</volume>             <fpage>669</fpage>             <lpage>74</lpage>          </element-citation></ref><ref id="pone.0018948-World2"><label>75</label><element-citation publication-type="book">             <collab>World Health Organization</collab>             <year>2008</year>             <article-title>Priority interventions: HIV/AIDS prevention, treatment and care in the health sector.</article-title>             <publisher-loc>Geneva</publisher-loc>             <publisher-name>WHO</publisher-name>          </element-citation></ref><ref id="pone.0018948-Kalichman1"><label>76</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Kalichman</surname><given-names>SC</given-names></name><name><surname>Ramachandran</surname><given-names>B</given-names></name><name><surname>Catz</surname><given-names>S</given-names></name></person-group>             <year>1999</year>             <article-title>Adherence to combination antiretroviral therapies in HIV patients of low health literacy.</article-title>             <source>J Gen Intern Med</source>             <volume>14</volume>             <fpage>267</fpage>             <lpage>73</lpage>          <pub-id pub-id-type="pmid">10337035</pub-id></element-citation></ref><ref id="pone.0018948-Norman1"><label>77</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Norman</surname><given-names>A</given-names></name><name><surname>Chopra</surname><given-names>M</given-names></name><name><surname>Kadiyala</surname><given-names>S</given-names></name></person-group>             <year>2007</year>             <article-title>Factors related to HIV disclosure in 2 South African communities.</article-title>             <source>Am J Public Health</source>             <volume>97</volume>             <fpage>1775</fpage>             <lpage>81</lpage>          <pub-id pub-id-type="pmid">17761582</pub-id></element-citation></ref><ref id="pone.0018948-Ncama1"><label>78</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Ncama</surname><given-names>BP</given-names></name><name><surname>McInerney</surname><given-names>PA</given-names></name><name><surname>Bhengu</surname><given-names>BR</given-names></name><name><surname>Corless</surname><given-names>IB</given-names></name><name><surname>Wantland</surname><given-names>DJ</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa.</article-title>             <source>Int J Nurs Stud</source>             <volume>45</volume>             <fpage>1757</fpage>             <lpage>63</lpage>          <pub-id pub-id-type="pmid">18653188</pub-id></element-citation></ref><ref id="pone.0018948-Berg1"><label>79</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Berg</surname><given-names>KM</given-names></name><name><surname>Arnsten</surname><given-names>JH</given-names></name></person-group>             <year>2006</year>             <article-title>Practical and conceptual challenges in measuring antiretroviral adherence.</article-title>             <source>JAIDS</source>             <volume>43</volume>             <fpage>S79</fpage>             <lpage>S87</lpage>          <pub-id pub-id-type="pmid">17133207</pub-id></element-citation></ref><ref id="pone.0018948-Liu1"><label>80</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Golin</surname><given-names>CE</given-names></name><name><surname>Miller</surname><given-names>LG</given-names></name><name><surname>Hays</surname><given-names>RD</given-names></name><name><surname>Beck</surname><given-names>CK</given-names></name><etal/></person-group>             <year>2001</year>             <article-title>A comparison study of multiple measures of adherence to HIV protease inhibitors.</article-title>             <source>Ann Intern Med</source>             <volume>137</volume>             <fpage>968</fpage>             <lpage>977</lpage>          <pub-id pub-id-type="pmid">11352698</pub-id></element-citation></ref><ref id="pone.0018948-Nachega2"><label>81</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Nachega</surname><given-names>JB</given-names></name><name><surname>Mills</surname><given-names>EJ</given-names></name><name><surname>Schechter</surname><given-names>M</given-names></name></person-group>             <year>2010</year>             <article-title>Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities.</article-title>             <source>Curr Opin HIV AIDS</source>             <volume>5</volume>             <fpage>70</fpage>             <lpage>77</lpage>          <pub-id pub-id-type="pmid">20046150</pub-id></element-citation></ref><ref id="pone.0018948-Wagner1"><label>82</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>LG</given-names></name></person-group>             <year>2004</year>             <article-title>Is the influence of social desirability on patients' self-reported adherence overrated?</article-title>             <source>JAIDS</source>             <volume>35</volume>             <fpage>203</fpage>             <lpage>204</lpage>          <pub-id pub-id-type="pmid">14722455</pub-id></element-citation></ref><ref id="pone.0018948-Castro1"><label>83</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Castro</surname><given-names>A</given-names></name></person-group>             <year>2005</year>             <article-title>Adherence to antiretroviral therapy: merging the clinical and social course of AIDS.</article-title>             <source>PLoS Med</source>             <volume>2</volume>             <fpage>e338</fpage>          <pub-id pub-id-type="pmid">16187735</pub-id></element-citation></ref><ref id="pone.0018948-Naik1"><label>84</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Naik</surname><given-names>E</given-names></name><name><surname>Casanas</surname><given-names>B</given-names></name><name><surname>Pazare</surname><given-names>A</given-names></name><name><surname>Wabale</surname><given-names>G</given-names></name><name><surname>Sinnott</surname><given-names>J</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Cost of treatment: the single biggest obstacle to HIV/AIDS treatment adherence in lower-middle class patients in Mumbai, India.</article-title>             <source>Ind J Sex Transmit Dis</source>             <volume>40</volume>             <fpage>23</fpage>             <lpage>27</lpage>          </element-citation></ref><ref id="pone.0018948-Mondloch1"><label>85</label><element-citation publication-type="journal">             <person-group person-group-type="author"><name><surname>Mondloch</surname><given-names>MV</given-names></name><name><surname>Cole</surname><given-names>DC</given-names></name><name><surname>Frank</surname><given-names>JW</given-names></name></person-group>             <year>2001</year>             <article-title>Does how you do depend on how you think you'll do? A systematic review of the evidence for a relation between patients' recovery expectations and health outcomes.</article-title>             <source>CMAJ</source>             <volume>165</volume>             <fpage>174</fpage>             <lpage>79</lpage>          <pub-id pub-id-type="pmid">11501456</pub-id></element-citation></ref></ref-list></back></article>